<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date>05/17/2022</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Mohsen</forename><surname>Naghavi</surname></persName>
							<email>nagham@uw.edu</email>
						</author>
						<author>
							<persName><roleName>MD;</roleName><forename type="first">Chandrashekhar</forename><forename type="middle">T</forename><surname>Sreeramareddy</surname></persName>
						</author>
						<author>
							<persName><roleName>Hansen, Woodbrook</roleName><forename type="first">Lalit</forename><surname>Dandona</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Haidong</forename><surname>Wang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">;</forename><surname>Stein</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, DrPH</roleName><forename type="first">Emil</forename><surname>Vollset</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Ali</forename><surname>Mokdad</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Joshua</forename><forename type="middle">A</forename><surname>Salomon</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Rafael</forename><surname>Lozano</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD;</roleName><forename type="first">Theo</forename><surname>Vos</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Mohammad</forename><surname>Forouzanfar</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Alan</forename><surname>Lopez</surname></persName>
						</author>
						<author>
							<persName><roleName>DPhil, MD;</roleName><forename type="first">Christopher</forename><surname>Murray</surname></persName>
						</author>
						<author>
							<persName><roleName>Dicker, Pain, Hamavid, Moradi-Lakeh</roleName><surname>Fitzmaurice</surname></persName>
						</author>
						<author>
							<persName><roleName>Mokdad, Lozano, Vos, Forouzanfar</roleName><surname>Wang</surname></persName>
						</author>
						<author>
							<persName><surname>Murray</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Health Department</orgName>
								<orgName type="department" key="dep2">Institute for Health Metrics and Evaluation</orgName>
								<orgName type="institution">University of Washington</orgName>
								<address>
									<addrLine>2301 Fifth Ave, Ste 600</addrLine>
									<postCode>98121</postCode>
									<settlement>Seattle</settlement>
									<region>WA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Institute for Health Metrics and Evaluation</orgName>
								<orgName type="laboratory">Affiliations of The Global Burden of Disease Cancer Collaboration: Division of Hematology</orgName>
								<orgName type="institution">University of Washington</orgName>
								<address>
									<settlement>Seattle (Fitzmaurice)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">University of Washington</orgName>
								<address>
									<settlement>Seattle</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Gastrointestinal and Liver Disease Research Center</orgName>
								<orgName type="institution">Naghavi)</orgName>
								<address>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution">University of Medical Sciences</orgName>
								<address>
									<settlement>Tehran</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution">Iran (Moradi-Lakeh); King&apos;s College London</orgName>
								<address>
									<addrLine>England (Wolfe)</addrLine>
									<settlement>London</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">Arabian Gulf University</orgName>
								<address>
									<settlement>Manama</settlement>
									<country>Bahrain (Hamadeh</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="institution">University of North Texas</orgName>
								<address>
									<addrLine>Denton (Moore)</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="department">Institute of Medical Sociology and Social Medicine</orgName>
								<address>
									<settlement>Marburg</settlement>
									<country>Germany (Werdecker</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Agence de Medecine Preventive</orgName>
								<address>
									<settlement>Paris</settlement>
									<country>France (Gessner</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Department of Biostatistics and Epidemiology</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department">School of Public Health and Psychosocial Studies</orgName>
								<orgName type="institution">Auckland University of Technology</orgName>
								<address>
									<settlement>Auckland</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department">College of Physicians and Surgeons</orgName>
								<orgName type="institution" key="instit1">New Zealand (Te Ao); Liver Disease and Hepatitis Program</orgName>
								<orgName type="institution" key="instit2">Alaska Native Tribal Health Consortium</orgName>
								<address>
									<settlement>Anchorage, Alaska (McMahon)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="institution">Columbia University</orgName>
								<address>
									<settlement>New York</settlement>
									<region>New York (Karimkhani)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="institution">Wuhan University</orgName>
								<address>
									<addrLine>China (Yu)</addrLine>
									<settlement>Wuhan</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country>England (Cooke</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of Alabama at Birmingham</orgName>
								<address>
									<settlement>Birmingham</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="department">Alabama (Schwebel)</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="department">Institute for Health and the Environment</orgName>
								<orgName type="laboratory">Laboratório de Farmacognosia</orgName>
								<orgName type="institution">University at Albany</orgName>
								<address>
									<settlement>Rensselaer</settlement>
									<region>New York (Carpenter)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="department" key="dep1">Departamento de Ciências Químicas</orgName>
								<orgName type="department" key="dep2">Faculdade de Farmácia</orgName>
								<orgName type="institution" key="instit1">University do Porto</orgName>
								<orgName type="institution" key="instit2">REQUIMTE/LAQV</orgName>
								<address>
									<settlement>Porto</settlement>
									<country>Portugal (Pereira</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="department" key="dep1">School of Public Health</orgName>
								<orgName type="department" key="dep2">San Francisco (Kazi)</orgName>
								<orgName type="institution" key="instit1">Hunter College Campus</orgName>
								<orgName type="institution" key="instit2">City University of New York</orgName>
								<orgName type="institution" key="instit3">University of California</orgName>
								<orgName type="institution" key="instit4">Griffith University</orgName>
								<address>
									<settlement>Brisbane</settlement>
									<region>New York (Nash)</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">De Leo)</orgName>
								<orgName type="department" key="dep2">Department of Internal Medicine</orgName>
								<orgName type="laboratory">Federal Environment Agency Section on Exposure Assessment and Environmental Health Indicators</orgName>
								<orgName type="institution">Federal Teaching Hospital</orgName>
								<address>
									<settlement>Berlin, Abakaliki</settlement>
									<country>Germany (Plass), Nigeria (Ukwaja</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff22">
								<orgName type="institution">Nelson Institute of Environmental Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="department">Faculty of Chinese Medicine</orgName>
								<orgName type="institution">New York University School of Medicine</orgName>
								<address>
									<settlement>Tuxedo</settlement>
									<region>New York (Thurston)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="department">Rollins School of Public Health</orgName>
								<orgName type="institution">Southern University College</orgName>
								<address>
									<settlement>Johor</settlement>
									<region>Yun Jin)</region>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="institution">Emory University</orgName>
								<address>
									<settlement>Atlanta</settlement>
									<region>Georgia (Simard)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="institution">University of Ottawa</orgName>
								<address>
									<settlement>Ottawa</settlement>
									<region>Ontario</region>
									<country>Canada (Mills</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff27">
								<orgName type="department">Department of Medical Humanities and Social Medicine</orgName>
								<orgName type="institution">Kosin University College of Medicine</orgName>
								<address>
									<settlement>Busan</settlement>
									<country>South Korea (Park</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff28">
								<orgName type="department">Division of Pharmacoepidemiology and Pharmacovigilance</orgName>
								<orgName type="institution" key="instit1">Spanish Medicines and Healthcare Products Agency (AEMPS)</orgName>
								<orgName type="institution" key="instit2">Ministry of Health</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country>Spain (Catalá-López</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="department">School of Population and Public Health</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country>Canada (deVeber</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff30">
								<orgName type="institution">University of British Columbia</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<region>British Columbia</region>
									<country>Canada (Gotay, Krueger</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff31">
								<orgName type="department">Department of Microbiology &amp; Immunology</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff32">
								<orgName type="department">College of Medicine and Health Sciences</orgName>
								<orgName type="institution">Emirates University</orgName>
								<address>
									<settlement>Al-Ain</settlement>
									<country>United Arab, United Arab</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff33">
								<orgName type="institution" key="instit1">Emirates (Khan)</orgName>
								<orgName type="institution" key="instit2">Albert Einstein College of Medicine</orgName>
								<address>
									<settlement>Bronx</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff34">
								<orgName type="laboratory">Centre for Clinical and Epidemiological Research</orgName>
								<orgName type="institution" key="instit1">New York (Hosgood)</orgName>
								<orgName type="institution" key="instit2">University of São Paulo</orgName>
								<address>
									<addrLine>Lotufo)</addrLine>
									<settlement>São Paulo, Brazil (Santos</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff35">
								<orgName type="institution">Nova Southeastern University</orgName>
								<address>
									<settlement>Fort Lauderdale</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff36">
								<orgName type="department">Division of Clinical Immunology and Rheumatology</orgName>
								<orgName type="institution" key="instit1">Florida (Leasher)</orgName>
								<orgName type="institution" key="instit2">University of Alabama at Birmingham</orgName>
								<address>
									<settlement>Birmingham, Alabama (Singh)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff37">
								<orgName type="institution">University of Sydney (Leigh)</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff38">
								<orgName type="department">Department of Ophthalmology</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<settlement>Mannheim</settlement>
									<country>Germany (Jonas</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff39">
								<orgName type="department">Department of Surgery</orgName>
								<orgName type="institution">Case Western Reserve University</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<region>Ohio (Sanabria</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff40">
								<orgName type="department" key="dep1">); Nutrition and Preventive Medicine</orgName>
								<orgName type="department" key="dep2">Chicago Medical School at Cancer Treatment Centers of America</orgName>
								<orgName type="institution">Rosalind Franklin University</orgName>
								<address>
									<settlement>Chicago</settlement>
									<region>Illinois (Sanabria)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff41">
								<orgName type="department">Nuffield Department of Medicine</orgName>
								<orgName type="institution">Oxford University</orgName>
								<address>
									<settlement>Ho Chi Minh City</settlement>
									<country>Vietnam (Beardsley</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff42">
								<orgName type="department">Department of Global and Community Health</orgName>
								<orgName type="institution">George Mason University</orgName>
								<address>
									<settlement>Fairfax</settlement>
									<region>Virginia (Jacobsen)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff43">
								<orgName type="department">Department of Environmental Epidemiology</orgName>
								<orgName type="institution">University of Occupational and Environmental Health</orgName>
								<address>
									<settlement>Kitakyushu</settlement>
									<country>Japan (Takahashi</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff44">
								<orgName type="department">College of Public Health, Medical and Veterinary Sciences</orgName>
								<orgName type="institution">James Cook University</orgName>
								<address>
									<settlement>Townsville</settlement>
									<region>Franklin)</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff45">
								<orgName type="department">Institute for Maternal</orgName>
								<orgName type="institution">Child Health IRCCS Burlo Garofolo</orgName>
								<address>
									<settlement>Trieste, Montico</settlement>
									<region>Monasta)</region>
									<country>Italy (Ronfani</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff46">
								<orgName type="institution">Azienda Ospedaliera papa Giovanni XXIII</orgName>
								<address>
									<settlement>Bergamo</settlement>
									<country>Italy (Naldi</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff47">
								<orgName type="department">Division of Human Nutrition</orgName>
								<orgName type="institution">University of Calgary</orgName>
								<address>
									<settlement>Calgary</settlement>
									<region>Alberta</region>
									<country>Canada (Tonelli</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff48">
								<orgName type="department">Centre for Applied Biostatistics</orgName>
								<orgName type="institution">Wageningen University</orgName>
								<address>
									<settlement>Wageningen</settlement>
									<country>the Netherlands (Geleijnse</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff49">
								<orgName type="institution" key="instit1">Sahlgrenska Academy</orgName>
								<orgName type="institution" key="instit2">University of Gothenburg</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country>Sweden (Petzold</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff50">
								<orgName type="department">School of Public Health</orgName>
								<orgName type="institution">University of the Witwatersrand</orgName>
								<address>
									<settlement>Johannesburg</settlement>
									<country>South Africa (Petzold</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff51">
								<orgName type="institution">Harvard University</orgName>
								<address>
									<addrLine>Campos)</addrLine>
									<settlement>Boston, Shrime</settlement>
									<region>Massachusetts</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff52">
								<orgName type="department">National Center of Neurology and Psychiatry</orgName>
								<orgName type="institution">Jackson State University</orgName>
								<address>
									<settlement>Jackson, Kodira</settlement>
									<region>Mississippi (Younis)</region>
									<country>Japan (Yonemoto</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff53">
								<orgName type="institution">University of Arizona</orgName>
								<address>
									<settlement>Tucson (Breitborde)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff54">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
									<country>China (Yip</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff55">
								<orgName type="laboratory">Endocrinology and Metabolism Research Center</orgName>
								<orgName type="institution">University of British Columbia</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<region>British Columbia</region>
									<country>Canada (Pourmalek</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff56">
								<orgName type="department">School of Medicine and Pharmacology</orgName>
								<orgName type="institution">Tehran University of Medical Sciences</orgName>
								<address>
									<addrLine>Hafezi-Nejad)</addrLine>
									<settlement>Tehran, Sheikhbahaei</settlement>
									<country>Iran (Esteghamati</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff57">
								<orgName type="department" key="dep1">School of Medicine and Pharmacology</orgName>
								<orgName type="department" key="dep2">Nuffield Department of Population Health</orgName>
								<orgName type="institution">University of Western Australia (Hankey)</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff58">
								<orgName type="department">Department of Neuropsychopharmacology</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<addrLine>England (Ali)</addrLine>
									<settlement>Oxford</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff59">
								<orgName type="department">Digestive Disease Research Institute</orgName>
								<orgName type="institution">Aintree University Hospital NHS Foundation Trust</orgName>
								<address>
									<settlement>Liverpool</settlement>
									<country>England (Lunevicius</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff60">
								<orgName type="institution">Tehran University of Medical Sciences</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country>Iran (Malekzadeh</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff61">
								<orgName type="department">Denver (Dellavalle)</orgName>
								<orgName type="institution">Veterans Affairs Eastern Colorado Health Care System</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff62">
								<orgName type="department" key="dep1">Department of Dermatology</orgName>
								<orgName type="department" key="dep2">Denver (Dellavalle)</orgName>
								<orgName type="institution" key="instit1">University of Colorado School of Medicine</orgName>
								<orgName type="institution" key="instit2">University of Melbourne</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<country>Australia (Weintraub</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff63">
								<orgName type="laboratory">National Centre for Epidemiology and Population Health</orgName>
								<orgName type="institution">Royal Children&apos;s Hospital</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>Weintraub)</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff64">
								<orgName type="department" key="dep1">International Foundation for Dermatology</orgName>
								<orgName type="department" key="dep2">Centre of Research in Environmental Epidemiology (CREAL)</orgName>
								<orgName type="institution" key="instit1">Research School of Population Health</orgName>
								<orgName type="institution" key="instit2">The Australian National University</orgName>
								<address>
									<settlement>Canberra, London, Barcelona</settlement>
									<region>Lucas)</region>
									<country>Australia, England (Hay), Spain (Rojas-Rueda</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff65">
								<orgName type="institution">University of Marburg</orgName>
								<address>
									<settlement>Marburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff66">
								<orgName type="institution" key="instit1">(Westerman); Digestive Diseases Research Institute</orgName>
								<orgName type="institution" key="instit2">Shariati Hospital</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country>Iran (Sepanlou</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff67">
								<orgName type="department">Department of Community Health Sciences</orgName>
								<orgName type="institution">Charité University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country>Germany (Nolte</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff68">
								<orgName type="institution">University of Calgary</orgName>
								<address>
									<settlement>Calgary</settlement>
									<region>Alberta</region>
									<country>Canada (Patten</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff69">
								<orgName type="institution">Air Health Science Division</orgName>
								<address>
									<settlement>Ottawa</settlement>
									<region>Health Canada, Ontario</region>
									<country>Canada (Weichenthal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff70">
								<orgName type="institution">College of Health Sciences</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff71">
								<orgName type="department">of Global Public Health and Primary Care</orgName>
								<orgName type="institution">University of Bergen</orgName>
								<address>
									<settlement>Bergen</settlement>
									<country>Norway (Vollset</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff72">
								<orgName type="institution">Norwegian Institute of Public Health</orgName>
								<address>
									<settlement>Bergen</settlement>
									<country>Norway (Vollset</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff73">
								<orgName type="institution">Harvard University</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts (Salomon)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff74">
								<orgName type="department">School of Population and Global Health</orgName>
								<orgName type="institution">National Institute of Public Health</orgName>
								<address>
									<settlement>Cuernavaca, Mexico (Lozano)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff75">
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>Lopez)</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<imprint>
							<date type="published">05/17/2022</date>
						</imprint>
					</monogr>
					<idno type="MD5">D66F4099584131DB1180EA862EEF8850</idno>
					<idno type="DOI">10.1001/jamaoncol.2015.0735</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Clinical Review &amp; Education Special Communication</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Global Burden of Disease Cancer Collaboration</head><p><s>IMPORTANCE Cancer is among the leading causes of death worldwide.</s><s>Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies.</s><s>OBJECTIVE To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EVIDENCE REVIEW</head><p><s>The general methodology of the Global Burden of Disease (GBD) 2013 study was used.</s><s>Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios.</s><s>Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources.</s><s>The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates.</s><s>Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs.</s></p><p><s>FINDINGS In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs.</s><s>Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million).</s><s>Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths.</s><s>For men, TBL cancer was the leading cause of DALYs (24.9 million).</s><s>For women, breast cancer was the leading cause of DALYs (13.1 million).</s><s>Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3).</s><s>Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10% in 113 countries and decreased by more than 10% in 12 of 188 countries.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSIONS AND RELEVANCE</head><p><s>Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990.</s><s>The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments.</s><s>The annual update on the Global Burden of Cancer will provide all stakeholders with timely estimates to guide policy efforts in cancer prevention, screening, treatment, and palliation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>The general methods that have been used in the GBD study have been published previously. 1,2,7-14</s><s>The present study specifically explains the methodological components pertaining to cancer estimation for GBD 2013.</s><s>Box 1 includes a list of the figures and tables in this article.</s><s>Further details about methods and data sources are provided in the eAppendix, eFigures, and eTables in the Supplement, and Box 2 contains a list of the supplementary figures and tables.</s><s>Additional information is available from the authors in web tables 1 through 9, which are available at the web addresses listed in Box 3. Hereinafter, citations to web tables are for those given in Box 3.</s></p><p><s>The analytical strategy can be broken into 7 components, as shown in eFigure 1 in the Supplement.</s><s>The first step involved extraction of mortality and incidence data from data sources collected for the GBD study.</s><s>Data on cancer incidence and cancer mortality were sought from individual cancer registries, literature reviews, and the Cancer Incidence in Five Continents (CI5) series. 15-24</s><s>Only data representative of the registries' catchment area and including all cancer sites for both sexes were used.</s><s>The most recent data available for any source until 2012 were incorporated.</s><s>eTable 1 in the Supplement lists cancer registry data used by country.</s><s>Just over half (53%) of cancer incidence data were reported in CI5, whereas 47% came from cancer registries from other sources.</s><s>Data were extracted at the most detailed cause-and age-specific level.</s><s>International Classification of <ref type="bibr">Diseases,</ref> and International Classification of <ref type="bibr">Diseases,</ref> codes for each GBD cancer group as well as steps explaining data preparation can be found in the eAppendix in the Supplement.</s><s>Twentyeight cancer groups were defined that include all ICD codes pertaining to neoplasms (ICD-9, 140-239; ICD-10, C00-D49) except for Kaposi sarcoma (KS) (C46) and nonmelanoma skin cancer (NMSC) (C44).</s><s>eTable 3 in the Supplement lists the ICD-9 and ICD-10 codes included in each cancer group.</s></p><p><s>In the second step, mortality incidence (MI) ratios (cancer deaths divided by cancer incident cases) were estimated for each cancer site, country, age, sex, and year.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>At a Glance</head><p><s>• In 2013, there were 14.9 million new cancer cases and 8.2 million cancer deaths.</s><s>• For women, breast cancer was the leading cause of disability-adjusted life-years (DALYs) globally and in developed and developing countries.</s><s>• For men, lung cancer was the leading cause of DALYs globally and in developed and developing countries.</s><s>• For men, incident cases have increased the most for prostate cancer at the global setting and in developed and developing countries.</s><s>• For women at the global level, incident cases have increased the most for non-Hodgkin lymphoma; in developed countries, incident cases have increased the most for kidney cancer; in developing countries, incident cases have increased the most for breast cancer.</s><s>In the third step, the MI ratios were applied to cancer incidence data to transform incidence data to mortality estimates.</s><s>Mortality data from cancer registries were only used to generate MI ratios and did not contribute to the cancer mortality estimates to avoid counting the cancer registry data twice.</s><s>eTable 1 in the Supplement lists which cancer registry data were used for MI ratio estimation.</s><s>The incidence-based mortality estimates became part of the GBD CoD (cause of death) database.</s><s>The methods used to generate the CoD database are reported in detail elsewhere. 1</s><s>In brief, all published and unpublished data relevant to estimating causes of death for 188 countries from 1980 to 2013 were identified.</s><s>The sources include vital registration systems, verbal autopsy studies, and other sources (eTable 2 in the Supplement).</s><s>Cancer registry data contributed 37% to the cancer-specific data in the CoD database; the other sources contributed 63%.</s></p><p><s>In the fourth step, the CoD database mortality data (including the cancer incidence data transformed to mortality estimates through the use of MI ratios) were used as input into the Cause of Death Ensemble Model (CODEm) to estimate the number of deaths attributable to each cancer assessed in the analysis. 25</s><s>The CODEm results were adjusted using CoDcorrect, an algorithm that uses uncertainty distributions around cause fraction estimates for each GBD cause of death to scale estimates to all-cause mortality estimates in each country, year, age, and sex group.</s><s>These death estimates were used to calculate years of life lost (YLLs).</s></p><p><s>The fifth step was to apply MI ratios to CoDcorrect death estimates to obtain cancer incidence estimates for each country, year, age, and sex group.</s></p><p><s>In the sixth step, MI ratios were transformed into an access-tocare variable to scale countries between a theoretical best-case and worst-case survival to generate relative survival curves.</s><s>The relative survival was then adjusted for background mortality using GBD life-tables, and absolute survival rates were estimated.</s></p><p><s>In step 7, the absolute survival estimates were used to generate 10-year cancer prevalence estimates.</s><s>Total prevalence was subdivided into general cancer sequelae like (1) diagnosis and treatment, (2) metastatic phase, and (3) terminal phase for the estimated deaths.</s><s>After these 3 sequelae were assigned, the remaining prevalent time was considered remission.</s><s>Prevalence for cancer-specific sequelae for breast cancer (mastectomy), larynx cancer (laryngectomy), colon and rectum cancer (stoma), bladder cancer (incontinence), and prostate cancer (impotence and incontinence) was also estimated.</s><s>To calculate years lived with disability (YLDs), each sequela was multiplied with specific disability weights, which were de-rived from population-based surveys. 11,26</s><s>Disability-adjusted lifeyears (DALYs), which combine health loss with premature mortality, were calculated by using the sum of YLLs and YLDs.</s><s>This analysis does not provide estimates for NMSC or KS because NMSC is an exceptional cancer with a very high incidence, which is usually not collected by cancer registries, and low mortality, and KS is attributed to human immunodeficiency virus in the GBD framework.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Global Incidence, Mortality, and DALYs</head><p><s>In 2013, there were 14.9 million incident cancer cases worldwide and 8.2 million cancer deaths as detailed in Table <ref type="table" target="#tab_0">1</ref>.</s><s>Cancer caused 196.3 million DALYs in 2013 (web table <ref type="table">9</ref>); 56% of incident cases, 62% of deaths, and 70% of DALYs occurred in developing countries.</s><s>eFigure 5 in the Supplement shows that between 1990 and 2013, the proportion of deaths from noncommunicable diseases (NCDs) substantially increased (from 57% in 1990 to 70% in 2013), with a decrease in deaths due to communicable, maternal, neonatal, and nutritional diseases <ref type="bibr">(from 34% in 1990 to 22% in 2013)</ref>.</s><s>The proportion of cancer deaths as part of all deaths has increased from <ref type="bibr">12% in 1990</ref><ref type="bibr">12% in to 15% in 2013</ref><ref type="bibr">12% in . Between 1990</ref><ref type="bibr">12% in and 2013, absolute , absolute</ref> DALYs due to all cancers (excluding NMSC and KS) for both sexes increased by 29% globally, by 10% in developed countries, and by 40% in developing countries.</s><s>Age-standardized DALYs decreased by 20% globally, by 21% in developed countries, and by 18% in developing countries (web table <ref type="table">9</ref>).</s></p><p><s>Men were more likely to develop cancer between birth and age 79 years, with 1 in 3 men and 1 in 5 women developing cancer worldwide, as detailed in eTable 17 in the Supplement.</s><s>In 2013, the cancers with the highest incidence on a global scale for men were prostate cancer (1.4 million), tracheal, bronchus, and lung (TBL) cancer (1.3 million), and colon and rectum cancer (873 000), as detailed in Table <ref type="table" target="#tab_0">1</ref>.</s><s>The top 3 causes of cancer death and DALYs for men were TBL cancer (1.2 million deaths, 24.9 million DALYs), liver cancer (564 000 deaths, 15.2 million DALYs), and stomach cancer (530 000 deaths, 11.7 million DALYs) (Table <ref type="table" target="#tab_0">1</ref>; web table <ref type="table">6</ref>).</s><s>For women, the cancers with the highest incidence were breast cancer (1.8 million), colon and rectum cancer (700 000), and TBL cancer (535 000).</s><s>The top 3 causes of cancer death for women were TBL cancer (485 000), breast cancer (464 000), and colon and rectum cancer (357 000) (Table <ref type="table" target="#tab_0">1</ref>).</s><s>In 2013, the top 3 causes for DALYs in women were breast cancer (13.1 million), TBL cancer <ref type="bibr">(9.8 million)</ref>, and cervical cancer (6.9 million) (web table <ref type="table">3</ref>).</s></p><p><s>The contribution of different cancers to total incidence and death by age group is shown in Figure <ref type="figure" target="#fig_1">1</ref>.</s><s>Brain and nervous system cancer, Hodgkin lymphoma, non-Hodgkin lymphoma (NHL), leukemia, and the combined "other cancer" group (a group containing rare cancers like malignant neoplasm of bone and articular cartilage of limbs, malignant neoplasm of thymus, and others-see eTable 15 in the Supplement for a full list of ICD codes) are the main contributors to cancer incidence in children and adolescents (age &lt;20 years).</s><s>Brain and nervous system cancer, NHL, leukemia, and cancers from the other cancer group cause most of the cancer deaths in this young age group.</s><s>In young and middle-aged adults breast, cervical, colon and rectum cancer, brain and nervous system cancer, and cancers from the other cancer group add the largest fraction to total incidence.</s><s>Stomach, liver, TBL, and breast cancer contribute the most to cancer deaths.</s><s>For older adults (&gt;54 years) stomach, TBL, breast, prostate, and colon and rectum cancers are the biggest contributors to incidence.</s><s>Stomach, liver, TBL, and colon and rectum cancer cause the majority of cancer deaths in older adults.</s></p><p><s>For all cancers combined (excluding NMSC and KS), ASIRs between 1990 and 2013 increased in 153 of 188 countries (Figure <ref type="figure">2A</ref>), with many countries in parts of Northern Africa and the Middle East, sub-Saharan Africa, Southeast Asia, and Oceania having experienced increases of over 20%.</s><s>However, ASDRs for all cancers combined (excluding NMSC and KS) decreased within that timeframe in 126 of 188 countries (Figure <ref type="figure">2B</ref>).</s><s><ref type="table">9</ref>).</s><s>Men were more likely to develop lung cancer than women, with 1 in 18 men and 1 in 51 women being diagnosed between birth and age 79 years.</s><s>Tracheal, bronchus, and lung cancer has the second highest absolute incidence globally as well as in developing countries and ranks fourth in developed countries (Figure <ref type="figure">3</ref>).</s><s>It was the most common cause of cancer death by absolute cases globally as well as in developing and developed regions (Figure <ref type="figure">4</ref>).</s><s>As detailed in web tables 4 and 5, ASIRs per 100 000 for men were the lowest in western sub-Saharan Africa (with ASDRs per 100 000 reported for comparison) <ref type="bibr">(ASIR,</ref><ref type="bibr">6.33;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">6.36)</ref>,</s><s>eastern sub-Saharan Africa (ASIR, 8.01; ASDR, 8.52), and central sub-Saharan Africa <ref type="bibr">(ASIR,</ref><ref type="bibr">12.77;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">13.08)</ref></s><s>and the highest in central Europe <ref type="bibr">(ASIR,</ref><ref type="bibr">66.10;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">63.87),</ref><ref type="bibr">east Asia (ASIR,</ref><ref type="bibr">64.68;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">60.13)</ref>,</s><s>and high-income North America (ASIR, 61.5; ASDR, 51.02).</s></p><p><s>For women in 2013, incidence rates per 100 000 were the lowest in western sub-Saharan Africa (with death rates per 100 000 reported for comparison) (ASIR, 2.76; ASDR, 2.96) followed by eastern sub-Saharan Africa <ref type="bibr">(ASIR,</ref><ref type="bibr">3.15;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">3.51)</ref>, and south Asia (ASIR, 3.80; ASDR, 4.12) and the highest in high-income North America <ref type="bibr">(ASIR,</ref><ref type="bibr">41.83;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">31.33),</ref><ref type="bibr">Australasia (ASIR,</ref><ref type="bibr">25.23;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">20.46),</ref><ref type="bibr">and east Asia (ASIR,</ref><ref type="bibr">22.88;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">22.16</ref>)</s><s>(web tables 1 and 2).</s><s>eFigure 6a and c in the Supplement shows that TBL cancer was the cancer with the most incident cases for men in 40 countries, with a predominance in central and eastern Europe, Asia, and northern Africa, and TBL was the most common cause for cancer death in 103 countries.</s><s>For women, TBL cancer was the most common cause of cancer death in Albania, Andorra, Australia, Brunei, Canada, China, Cuba, Denmark, United Kingdom, Hungary, Ireland, Iceland, Cambodia, South Korea, Laos, Myanmar, Netherlands, New Zealand, Poland, North Korea, Singapore, Timor-Leste, Taiwan, and the United States (eFigure 6d in the Supplement).</s><s>Between 1990 and 2013, TBL cancer remained the leading cause of cancer YLLs (Figure <ref type="figure" target="#fig_2">5</ref>).</s><s>A decrease in incidence rates between 1990 and 2013 with stable population size and age structure would have resulted in a 13% decrease in incident cases (Table <ref type="table" target="#tab_1">2</ref>).</s><s>However, overall incident cases increased by 62% because of population growth and aging.</s><s>The ASIRs per 100 000 for both sexes between 1990 and 2013 decreased by 6% at the global level <ref type="bibr">(31.12 to 29.36)</ref>, by 14% for developed countries (43.81 to 37.74) but increased by 9% in developing countries (23.04 to 25.18) (web <ref type="bibr">table 7)</ref>.</s></p><p><s>At the global level, incidence for women has risen slowly, whereas rates have fallen for men since the mid-1990s (Figure <ref type="figure" target="#fig_3">6</ref>).</s><s>The same trends can be seen in developed regions.</s><s>However, in developing regions, rates are still increasing for men.</s><s>Agestandardized DALY rates for both sexes between 1990 and 2013 have decreased by 17% at the global level, by 23% for developed countries, and by 7% for developing countries (web table <ref type="table">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Breast Cancer</head><p><s>Since only 1% of breast cancer cases in 2013 occurred in men, only female breast cancer is discussed herein.</s><s>In 2013, there were 1.8 million incident cases of breast cancer and 464 thousand deaths.</s><s>Breast cancer caused 13.1 million DALYs in 2013 (web table <ref type="table">3</ref>), with 63% occurring in developing countries and 37% occurring in developed countries.</s><s>One in 18 women developed breast cancer between birth and age 79 years.</s></p><p><s>As detailed in web tables 1 and 2, in 2013, ASIRs per 100 000 were the lowest in western sub-Saharan Africa (with ASDRs per 100 000 reported for comparison) (ASIR, 28.24; ASDR, 10.65), east Asia (ASIR, 33.52; ASDR, 6.87), and eastern sub-Saharan Africa (ASIR, <ref type="bibr">33.67;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">13.71</ref>)</s><s>and the highest in Oceania (ASIR, 133.38;</s><s>ASDR, 28.89), high-income North America (ASIR, 111.01;</s><s>ASDR, 19.07), and Australasia (ASIR, 91.12; ASDR, <ref type="bibr">19.63)</ref>.</s></p><p><s>Breast cancer was the cancer with the highest incidence for women in 161 countries (eFigure 6b in the Supplement) and the  most common cause for cancer deaths in women in 98 countries (eFigure 6d in the Supplement).</s></p><p><s>Figure <ref type="figure" target="#fig_2">5</ref> shows that breast cancer ranked sixth in 1990 for cancer YLLs, but it moved to fifth place in 2013.</s><s><ref type="bibr">Compared with 1990</ref><ref type="bibr">Compared with , in 2013</ref>, incident cases increased by 898 000 (99% increase).</s><s>With stable population size and age structure, breast cancer incidence would have increased by 26% due to increasing incidence rates.</s><s>Population aging with unchanged incidence rates or population growth would have led to a 38% increase in incidence (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Globally, female breast cancer incidence has been continuously increasing, with a slower increase since 2000 (Figure <ref type="figure">7</ref>).</s><s>Even though female breast cancer incidence is lower in developing countries, it is increasing rapidly compared with developed countries, where rates have been stable to declining since the early 2000s.</s><s>Between 1990 and 2013, ASIRs per 100 000 have increased by 17% globally (44.36 to 51.73), by 46% in developing countries <ref type="bibr">(27.74</ref>    d To estimate the effect of changing incidence rates on the incident cases we applied the incidence rates for 1990 onto the population size and age structure of 2013.</s><s>The change in incident cases reported herein shows the proportion of the change in incident cases between 1990 and 2013 that can be attributed to a change in incidence rates.</s></p><p><s>level, by 25% for developed countries, and by 3% for developing countries (web table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Colon and Rectum Cancer</head><p><s>In 2013, there were 1.6 million incident cases of colon and rectum cancer, and it caused 771 000 deaths.</s><s>Colon and rectum cancer caused 15.8 million DALYs in 2013, with 56% occurring in developing countries and 44% occurring in developed countries (web table <ref type="table">9</ref>).</s><s>The probability of developing colon and rectum cancer before age 79 years was higher for men than for women (1 in 27 men; 1 in 43 women).</s><s>Globally, colon and rectum cancer ranked third for cancer incidence and fourth for cancer death in 2013 (Figures <ref type="figure">3 and 4</ref>).</s><s>For developed countries it ranked second for incidence and mortality, and in developing countries it ranked fourth for both incidence and mortality.</s></p><p><s>As detailed in in web tables 4 and 5, the 2013 incidence rates per 100 000 for men were the lowest in western sub-Saharan Africa (with ASDRs per 100 000 reported for comparison) (ASIR, 9.12; ASDR, 6.51), south Asia (ASIR, 10.26; ASDR, 6.07), and eastern sub-Saharan Africa (ASIR, 12.73; ASDR, 9.91) and the highest in Australasia (ASIR, 60.64; ASDR, 22.29), high-income Asia Pacific (ASIR, 58.48; ASDR, 22.56), and western Europe (ASIR, 55.69; ASDR, 24.24).</s><s>For women, incidence rates per 100 000 in 2013 were the lowest in south Asia (with ASDRs per 100 000 reported for comparison) (ASIR, 6.04; ASDR, 3.98), western sub-Saharan Africa (ASIR, 6.95; ASDR, 5.49), and eastern sub-Saharan Africa (ASIR, 9.86; ASDR, 8.57) and the highest in Australasia (ASIR, 43.75; ASDR, 15.95), highincome North America (ASIR, 39.95; ASDR, 13.12), and western Europe (ASIR, 33.96; ASDR, 15.01) (web tables 1 and 2).</s><s>eFigure 6a and c in the Supplement show that colon and rectum cancer was the cancer with the highest incidence in 2013 for men in Bulgaria, Brunei, Hungary, Japan, Kuwait, Saudi Arabia, Singapore, Slovakia, and Taiwan and the most common cause of cancer death in Ethiopia and Tanzania.</s><s>For women, colon and rectum cancer was the cancer with the highest incidence in Japan and the most common cause of death in Spain, Japan, Norway, Portugal, and Sweden (eFigure 6b and d in the Supplement).</s></p><p><s>Figure <ref type="figure" target="#fig_2">5</ref> shows that colon and rectum cancer remained the fourth leading cause for cancer YLLs between 1990 and 2013.</s><s>Table <ref type="table" target="#tab_1">2</ref> details how in 2013 almost twice as many people were diagnosed with colon and rectum cancer as in 1990 (818 000 in 1990, 1.6 million in 2013).</s><s>Most of this increase can be explained by an aging and growing population, but even with the same population size and structure, colon and rectum cancer cases would have increased by 16% between 1990 and 2013 due to an increase in incidence rates.</s></p><p><s>Figure <ref type="figure">8</ref> shows that worldwide ASIR for colon and rectum cancer for women between 1990 and 2013 remained stable but increased for men.</s><s>As detailed in web tables 1 and 4, ASIRs increased by 1% between 1990 and 2013 for women and by 16% for men.</s><s>In developed countries, ASIRs decreased by 3% in women and increased by 8% in men.</s><s>However, in developing regions, rates have risen rapidly, with a 53% increase in men and a 31% increase in women between 1990 and 2013.</s><s>Between 1990 and 2013, agestandardized DALY rates for both sexes have decreased by 15% at the global level, by 18% in developed countries, and by 2% in developing countries (web table <ref type="table">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Prostate Cancer</head><p><s>In 2013, there were 1.4 million incident cases of prostate cancer and 293 000 deaths.</s><s>Prostate cancer caused 4.8 million DALYs glob-  eFigure 6a and c in the Supplement shows that in 2013, prostate cancer was the cancer with the highest incidence for men in 104 of 188 countries, and the leading cause of cancer death for men in 24 countries.</s></p><p><s>Prostate cancer ranked 15th for cancer YLLs in 1990 and 13th in 2013 as can be seen in Figure <ref type="figure" target="#fig_2">5</ref>. Table <ref type="table" target="#tab_1">2</ref> details how the increasing incidence together with an aging and growing population have led to a more than 3-fold increase in prostate cancer cases since 1990 (454 000 in 1990, 1.4 million in 2013).</s><s>The ASIR for prostate cancer had the steepest increase between 1990 and 2013 of all cancers in men (Figure <ref type="figure">9</ref>).</s><s>As listed in web table 4, ASIRs per 100 000 increased by 69% globally <ref type="bibr">(32.42 to 54.68)</ref>, by 135% in developing countries <ref type="bibr">(13.29 to 31.25)</ref>, and by 63% in developed countries (61.51 to 100.29).</s><s>Prostate cancer incidence rates are still lower in developing countries than in developed countries, but because of a faster increase in rates in developing countries, the gap decreased between 1990 and 2013 from a 4-fold to a 3-fold difference.</s><s>During the same timeframe, age-standardized DALY rates have decreased by 3% at the global level and by 9% in developed countries but have increased by 28% in developing countries (web table <ref type="table">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Stomach Cancer</head><p><s>In 2013, there were 984 000 incident cases of stomach cancer and 841 000 deaths.</s><s>Stomach cancer caused 17.9 million DALYs in 2013, with 77% occurring in developing countries, and 23% occurring in developed countries (web table <ref type="table">9</ref>).</s><s>One in 36 men and 1 in 84 women developed stomach cancer before age 79 years.</s><s>Globally, stomach cancer ranked fifth for cancer incidence and second for cancer deaths in 2013 (Figures <ref type="figure">3 and 4</ref>).</s><s>For developed countries, it ranked fifth for incidence and third for mortality, and in developing countries, it ranked third for both incidence and mortality.</s></p><p><s>The ASIRs and ASDRs per 100 000 in 2013 for both sexes were higher in developing countries vs developed countries (ASIR, 16.9 vs 14.38; ASDR, 15.33 vs 11.07) (web tables <ref type="table">7 and 8</ref>).</s><s>As detailed in web tables 4 and 5, the 2013 incidence rates per 100 000 for men were the lowest in southern sub-Saharan Africa (with ASDRs per 100 000 reported for comparison) (ASIR, 8.27; ASDR, 6.97), south Asia (ASIR, 9.01; ASDR, 9.19), and eastern sub-Saharan Africa (ASIR, 9.12; ASDR, 10.01) and the highest in high-income Asia Pacific (ASIR, 42.31; ASDR, 31.61),</s><s>east Asia (ASIR, 39.16; ASDR, 34.12), and Andean Latin America (ASIR, 32.61; ASDR, 27.96).</s><s>For women, incidence rates per 100 000 in 2013 were the lowest in southern sub-Saharan Africa (with ASDRs per 100 000 reported for comparison) (ASIR, 4.54; ASDR, 3.93), high-income North America (ASIR, 4.65; ASDR, 2.94), and Australasia (ASIR, 5.37; ASDR, 3.84) and the highest in Andean Latin America (ASIR, 24.62; ASDR, 21.69), highincome Asia Pacific (ASIR, 20.00; ASDR, 14.86), and east Asia (ASIR, 14.78; ASDR, 13.37) (web tables 1 and 2).</s><s>Stomach cancer was the cancer with the highest absolute incidence in 2013 for men in Honduras, Iran, Kyrgyzstan, and Tajikistan and the leading cause of cancer death in Bolivia, Central African Republic, Chile, Democratic Republic of the Congo, Congo, Colombia, Cape Verde, Costa Rica, Ecuador, Guatemala, Honduras, Iran, Kyrgyzstan, Oman, Peru, El Salvador, and Tajikistan (eFigure 6a and c in the Supplement).</s><s>For women, it was the cancer with the most incident cases in Cape Verde and the leading cause of cancer death in Afghanistan, Bolivia, Cape Verde, Ecuador, Guatemala, Honduras, Peru, Tajikistan, and Vietnam (eFigure 6b and d in the Supplement).</s></p><p><s>Stomach cancer decreased from the second highest cause for crude cancer YLLs in 1990 to the third highest in 2013, with a 2.5% decrease in absolute YLLs due to cancer (Figure <ref type="figure" target="#fig_2">5</ref>).</s><s>If the population age structure and size had remained the same in 2013 as it was in 1990, incidence would have dropped by 52.2% due to decreasing rates (Table <ref type="table" target="#tab_1">2</ref>).</s><s>As illustrated in Figure <ref type="figure" target="#fig_5">10</ref>, ASIRs have dropped substantially since 1990, Between 1990 and 2013 agestandardized DALYs for both sexes decreased by 42% globally, by 49% in developed countries, and by 40% in developing countries (web table <ref type="table">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Liver Cancer</head><p><s>In 2013, there were 792 000 incident cases of liver cancer globally and 818 000 deaths.</s><s>Liver cancer caused 20.9 million DALYs in 2013, with 86% occurring in developing countries and 14% occurring in developed countries (web table <ref type="table">9</ref>).</s><s>Liver cancer is more common in men, with 1 in 45 men being diagnosed before age 79 years compared with 1 in 121 women.</s><s>Globally, liver cancer ranked sixth for cancer incidence and third for cancer death in 2013 as shown in Figures <ref type="figure">3  and 4</ref>. For developed countries it ranked 11th for incidence and seventh for mortality, and in developing countries it ranked fifth for incidence and second for mortality.</s></p><p><s>The ASIRs and ASDRs for liver cancer per 100 000 in 2013 for both sexes were higher in developing countries vs developed countries <ref type="bibr">(ASIR,</ref><ref type="bibr">14.72 vs 7.42;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">15.59 vs 7.26</ref>) (web tables 7 and 8).</s><s>As web tables 4 and 5 detail, in 2013 incidence rates per 100 000 for men were the lowest in tropical Latin America (with ASDRs per 100 000 reported for comparison) <ref type="bibr">(ASIR,</ref><ref type="bibr">5.86;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">6.45),</ref><ref type="bibr">6.07;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">6.46),</ref><ref type="bibr">and Australasia (ASIR,</ref><ref type="bibr">6.26;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">5.69</ref>) and the highest in east Asia <ref type="bibr">(ASIR,</ref><ref type="bibr">36.66;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">36.88),</ref><ref type="bibr">30.53;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">33.68),</ref><ref type="bibr">and highincome Asia Pacific (ASIR,</ref><ref type="bibr">30.16;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">29.48)</ref>.</s><s>For women incidence rates in 2013 per 100 000 were the lowest in eastern Europe (ASIR, 2.52; ASDR, 2.85), Australasia (ASIR, 2.72; ASDR, 2.68), and high-income North America (ASIR, 2.87; ASDR, 2.72) and the highest in western sub-Saharan Africa (ASIR, 13.17; ASDR, 14.79), east Asia <ref type="bibr">(ASIR,</ref><ref type="bibr">11.89;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">13.09),</ref><ref type="bibr">and Oceania (ASIR,</ref><ref type="bibr">10.01;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">11.18)</ref></s><s>(web tables 1 and 2).</s></p><p><s>Liver cancer was the most commonly diagnosed cancer in 2013 for men in Benin, Burkina Faso, Cameroon, Guinea, The Gambia, Guinea-Bissau, Liberia, Mali, Mongolia, Mauritania, Niger, Senegal, Sierra Leone, Chad, Togo, Thailand, and Vietnam (eFigure 6a in the Supplement) and the most common cause of cancer death in <ref type="bibr">Burundi,</ref><ref type="bibr">Benin,</ref><ref type="bibr">Burkina Faso,</ref><ref type="bibr">Bangladesh,</ref><ref type="bibr">Côte d'Ivoire,</ref><ref type="bibr">Cameroon,</ref><ref type="bibr">Egypt,</ref><ref type="bibr">Eritrea,</ref><ref type="bibr">Fiji,</ref><ref type="bibr">Ghana,</ref><ref type="bibr">Guinea,</ref><ref type="bibr">The Gambia,</ref><ref type="bibr">Liberia,</ref><ref type="bibr">Madagascar,</ref><ref type="bibr">Mali,</ref><ref type="bibr">Mongolia,</ref><ref type="bibr">Mauritania,</ref><ref type="bibr">Niger,</ref><ref type="bibr">Nigeria,</ref><ref type="bibr">Rwanda,</ref><ref type="bibr">Saudi Arabia,</ref><ref type="bibr">Senegal,</ref><ref type="bibr">Sierra Leone,</ref><ref type="bibr">Chad,</ref><ref type="bibr">Togo,</ref><ref type="bibr">Thailand,</ref><ref type="bibr">Taiwan,</ref><ref type="bibr">and Vietnam (eFigure 6c in the Supplement)</ref>.</s></p><p><s>For women in 2013, liver cancer was the most commonly diagnosed cancer as well as the leading cause of cancer death in Mongolia (eFigure 6b and d in the Supplement).</s></p><p><s>Figure <ref type="figure">3</ref> shows a marked difference between the 50 most populous countries for liver cancer incidence rankings.</s><s>For example, while it ranks in most of these countries among the top 10 cancers for incidence, it ranks 21st in Ukraine, 19th in Poland, and 18th in the United States, the United Kingdom, Argentina, and Canada.</s></p><p><s>Liver cancer has increased from the third leading cause for cancer YLLs in 1990 to the second leading cause in 2013 (Figure <ref type="figure" target="#fig_2">5</ref>).</s><s>Aging and population growth are the drivers of the increase from 465 000 cases in 1990 to 792 000 cases in 2013 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>If the population age structure and size had remained the same in 2013 as they were in 1990, 1.8% fewer cases of liver cancer would have been diagnosed in 2013 than in 1990.</s><s>Worldwide, as well as in developing regions, ASIRs appear to have peaked in the late 1990s, with a slow decrease in rates since 2000 (Figure <ref type="figure" target="#fig_1">11</ref>).</s><s>Between 1990 and 2013, age-standardized DALY rates for both sexes for liver cancer decreased by 14% at the global level, by 20% in developing countries, and by 4% in developed countries (web table <ref type="table">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cervical Cancer</head><p><s>In 2013, 485 000 women were diagnosed with cervical cancer worldwide, and it caused 236 000 deaths.</s><s>Cervical cancer caused 6.9 million DALYs, with 85% occurring in developed countries and 15% occurring in developing countries.</s><s>One in 70 women developed cervical cancer between birth and age 79 years.</s><s>The ASIRs and ASDRs per 100 000 in 2013 were higher in developing countries vs developed countries (ASIR, 15.70 vs 9.58; ASDR, 8.32 vs 3.96) (web tables 1 and 2).</s><s>In 2013, incidence rates per 100 000 were the lowest in Australasia (with ASDRs per 100 000 reported for comparison) (ASIR, 6.83; ASDR, 2.65), north Africa and Middle East <ref type="bibr">(ASIR,</ref><ref type="bibr">7.23;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">3.19)</ref> and highincome North America (ASIR, 7.26; ASDR, 2.84), and the highest in Oceania <ref type="bibr">(ASIR,</ref><ref type="bibr">58.4;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">26.49)</ref>,</s><s>eastern sub-Saharan Africa <ref type="bibr">(ASIR,</ref><ref type="bibr">31.5;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">25.57)</ref>, and western sub-Saharan Africa (ASIR, <ref type="bibr">30.2;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">22.3)</ref>.</s></p><p><s>Cervical cancer was the most commonly diagnosed cancer in 2013 for women in Afghanistan, Benin, Central African Republic, Cameroon, Eritrea, Ghana, Guinea, The Gambia, Guinea-Bissau, Guatemala, Liberia, Lesotho, Mali, Mauritania, Malawi, Niger, Nigeria, Nicaragua, Senegal, Sierra Leone, El Salvador, Somalia, Chad, Togo, Uganda, Zambia, and Zimbabwe (eFigure 6b in the Supplement) and the most common cause of cancer death for women in Angola, Burundi, Benin, Burkina Faso, Central African Republic, Côte d'Ivoire, Cameroon, Democratic Republic of the Congo, Congo, Comoros, Djibouti, Eritrea, Ethiopia, Ghana, Guinea, Guinea-Bissau, Equatorial Guinea, Indonesia, Kenya, Liberia, Lesotho, Madagascar, Mali, Mozambique, Mauritania, Malawi, Niger, Nigeria, Nicaragua, Papua New Guinea, Paraguay, Rwanda, Senegal, Sierra Leone, El Salvador, Somalia, South Sudan, Sao Tome and Principe, Swaziland, Chad, Togo, Tanzania, Uganda, Zambia, and Zimbabwe (eFigure 6d in the Supplement).</s></p><p><s>Cervical cancer was the eighth leading cause for cancer YLLs in 1990 and the ninth leading cause in 2013, with a 32% decrease in age-standardized YLLs (Figure <ref type="figure" target="#fig_2">5</ref>).</s><s>Total incidence would have decreased by 59% if the population size and age structure had re-mained the same in 2013 as it was in 1990 due to decreasing incidence rates (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Both globally and in developing regions, ASIRs for cervical cancer have decreased (Figure <ref type="figure" target="#fig_1">12</ref>).</s><s>Between 1990 and 2013, age-standardized DALYs decreased globally by 32%, in developing countries by 36%, and in developed countries by 34% (web table <ref type="table">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Non-Hodgkin Lymphoma</head><p><s>In 2013, there were 465 000 incident cases of NHL and 226 000 deaths.</s><s>Non-Hodgkin lymphoma caused 6.4 million DALYs in 2013, with 71% occurring in developing countries and 29% occurring in developed countries (web table <ref type="table">9</ref>).</s><s>One in 103 men and 1 in 151 women developed NHL cancer between birth and age 79 years.</s></p><p><s>Globally, NHL ranked eighth for cancer incidence and 11th for cancer death in 2013 (Figures <ref type="figure">3 and 4</ref>).</s><s>For developed countries, it ranked seventh for incidence and ninth for mortality, and in developing countries it ranked 11th for both incidence and mortality.</s></p><p><s>As detailed in web tables 4 and 5, 2013 NHL incidence and rates per 100 000 for men were the lowest in Oceania (with ASDRs per  For women, NHL incidence rates per 100 000 in 2013 were the lowest in central Asia (ASIR, 2.35; ASDR, 1.32), western sub-Saharan Africa (ASIR, 2.68; ASDR, 1.96), and south Asia (ASIR, 3.27; ASDR, 2.37) and the highest in high-income North America (ASIR, 15.01; ASDR, 4.79), Australasia (ASIR, 10.74; ASDR, 4.71), and Western Europe (ASIR, 9.56; ASDR, 3.66) (web tables 1 and 2).</s><s>Non-Hodgkin lymphoma was the most commonly diagnosed cancer in 2013 for men in the United Arab Emirates and Qatar (eFigure 6a in the Supplement).</s></p><p><s>Non-Hodgkin lymphoma ranked 10th for cancer YLLs in 1990 and 11th in 2013 (Figure <ref type="figure" target="#fig_2">5</ref>).</s><s>More than twice as many cases of NHL were diagnosed in 2013 as in 1990 (465 000 vs 227 000).</s><s>Population growth alone would have increased incidence by 35%; population aging alone would have increased incidence by 30%; and an increase in incidence rates assuming stable population age structure and size between 1990 and 2013 would have led to a 41% increase in new cases (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Figure <ref type="figure" target="#fig_7">13</ref> illustrates the slight increase in ASIRs between 1990 and 2013.</s><s>On the global level, ASIRs per 100 000 for both sexes for NHL increased by 26% (5.8 to 7.3), with a larger increase in developing countries (44%, 3.6 to 5.2) than in developed countries (23%, 9.2 to 11.3) (web table <ref type="table">7</ref>).</s></p><p><s>During this timeframe, age-standardized DALY rates for both sexes decreased by 3% at the global level, by 8% in developing countries, and increased by 2% in developing countries (web table <ref type="table">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Esophageal Cancer</head><p><s>In 2013 there were 442 000 new cases of esophageal cancer and 440 000 deaths.</s><s>Esophageal cancer caused 9.8 million DALYs in 2013, with 84% occurring in developing countries and 16% occurring in developed countries (web table 9).</s><s>Men had a higher probability than women for developing esophageal cancer between birth and age 79 years, with 1 in 73 men being diagnosed vs 1 in 203 women.</s></p><p><s>Globally, esophageal cancer ranked ninth for cancer incidence and sixth for cancer death in 2013 (Figures <ref type="figure">3 and 4</ref>).</s><s>In developed countries, esophageal cancer was only the 20th greatest cause for cancer incidence but the 11th leading cause for cancer death.</s><s>In developing countries, esophageal cancer ranked eighth for cancer incidence and fifth for mortality.</s></p><p><s>Esophageal cancer ASIRs and ASDRs per 100 000 in 2013 for both sexes were higher in developing countries vs developed countries (ASIR, 8.94 vs 3.90; ASDR, 9.11 vs 3.79) (web tables 7 and 8).</s><s>As detailed in web tables 4 and 5, in 2013 incidence rates per 100 000 for men were the lowest in Andean Latin America (ASIR, 2.41; ASDR, 2.49), central Latin America (ASIR, 3.46; ASDR, 3.51), and north Africa and Middle East (ASIR, 3.46; ASDR, 3.74) and the highest in east Asia (ASIR, 22.04; ASDR, 22.4), southern sub-Saharan Africa <ref type="bibr">(ASIR,</ref><ref type="bibr">21.81;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">22.33)</ref>,</s><s>and central Asia <ref type="bibr">(ASIR,</ref><ref type="bibr">14.42;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">14.55)</ref>.</s><s>For women, incidence rates per 100 000 in 2013 were the lowest in Andean Latin America (with ASDRs per 100 000 reported for comparison) (ASIR, 0.64; ASDR, 0.64), eastern Europe (ASIR, 0.88; ASDR, 0.92), and central Europe (ASIR, 0.99 ASDR, 1.02) and the highest in eastern sub-Saharan Africa (ASIR, 12.74; ASDR, 13.78), southern sub-Saharan Africa (ASIR, 8.79; ASDR, 8.55), and south Asia (ASIR, 7.28; ASDR, 7.44) (web tables 1 and 2).</s></p><p><s>Esophageal cancer was the most commonly diagnosed cancer in 2013 for men in Malawi and Turkmenistan (eFigure 6a in the Supplement) and the most common cause of cancer death in Comoros, Djibouti, Kenya, Malawi, Somalia, South Sudan, Turkmenistan, and Zimbabwe (eFigure 6c in the Supplement).</s><s>For women, it was the most common cause of cancer death in 2013 in Iran and Turkmenistan (eFigure 6d in the Supplement).</s></p><p><s>Figure <ref type="figure">3</ref> shows a marked difference between the 50 most populous countries for esophageal cancer incidence rankings in 2013.</s><s>For example, while this cancer ranked in most countries among the least common cancers for incidence, it was the second most common cancer for both sexes in Kenya, and the fourth most common cancer in Iran.</s><s>The same holds true for cancer death rates, where esophageal cancer ranks first in Kenya and Nepal, second in Ethiopia, Iran, South Africa, and Uganda, but only 16th in the Philippines and 17th in Peru.</s><s>Esophageal cancer has increased from the seventh leading cause for cancer YLLs in 1990 to the sixth leading cause in 2013 (Figure <ref type="figure" target="#fig_2">5</ref>).</s><s>Aging and growing populations are the drivers behind the increase in esophageal cancer cases from 304 000 in 1990 to 442 000 in 2013.</s><s>If the population age structure and size had remained the same in 2013 as in 1990, 29.3% fewer cases of esophageal cancer would have been diagnosed in 2013 than in 1990 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Worldwide and in developing regions, age-standardized incidence rates appear to be declining (Figure <ref type="figure" target="#fig_8">14</ref>).</s><s>Between 1990 and 2013, agestandardized DALY rates for both sexes decreased by 23% globally, by 28% in developing countries, and by 18% in developed countries (web table <ref type="table">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Leukemia</head><p><s>In 2013, there were 414 000 new cases of leukemia worldwide and 265 000 deaths.</s><s>Leukemia caused 9.3 million DALYs globally, with 78% occurring in developing countries and 22% occurring in developed countries (web table <ref type="table">9</ref>).</s><s>One in 127 men vs 1 in 203 women developed leukemia between birth and age 79 years.</s></p><p><s>Globally, leukemia ranked 10th for cancer incidence and ninth for cancer deaths in 2013.</s><s>In developed countries, leukemia ranked 12th for incidence and eighth for cancer deaths.</s><s>In developing countries, it ranked 10th for cancer incidence and eighth for cancer deaths (Figures <ref type="figure">3 and 4</ref>).</s></p><p><s>The ASIRs and ASDRs per 100 000 in 2013 for both sexes were higher in developed countries vs developing countries (ASIR, 8.15 vs 5.09; ASDR, 4.78 vs 3.46) (web tables <ref type="table">7 and 8</ref>).</s><s>In 2013 incidence rates per 100 000 for both sexes were the lowest in western sub-Saharan Africa (with ASDRs per 100 000 reported for comparison) <ref type="bibr">(ASIR,</ref><ref type="bibr">1.34;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">1.15)</ref>,</s><s>eastern sub-Saharan Africa (ASIR, 1.58; ASDR, 1.47), and central sub-Saharan Africa (ASIR, 2.30; ASDR, 2.03) and highest in high-income North America <ref type="bibr">(ASIR,</ref><ref type="bibr">10.67;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">5.54),</ref><ref type="bibr">Australasia (ASIR,</ref><ref type="bibr">9.97;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">5.13),</ref><ref type="bibr">and Western Europe (ASIR,</ref><ref type="bibr">8.24;</ref><ref type="bibr">ASDR,</ref><ref type="bibr">5.08)</ref>.</s></p><p><s>Leukemia was the cancer with the most incident cases in 2013 for men in Iraq (eFigure 6a in the Supplement).</s><s>eFigure 4a in the Supplement shows a marked difference in incidence rankings between countries.</s><s>Leukemia ranks among the top most common cancers for both sexes in Iraq, Jordan, and Kuwait, while it is much less common in most other countries.</s><s>Leukemia has decreased from the fifth leading cause of cancer YLLs in 1990 to the seventh leading cause in 2013, with a 9% decrease in absolute YLLs and a 31% decrease in age-standardized YLLs (Figure <ref type="figure" target="#fig_2">5</ref>).</s></p><p><s>Between 1990 and 2013, incident cases at the global level increased from 297 000 to 414 000, with population growth and aging being the drivers behind this increase.</s><s>Had ASIRs remained the same in 2013 as in 1990, there would be 8% more cases of leukemia in 2013 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>For women, trends in ASIRs appear to be decreasing globally as well as in developed and developing countries (Figure <ref type="figure" target="#fig_9">15</ref>).</s><s>For men, ASIRs increased up to the mid-1990s and have decreased since in developing countries, with a stable trend in developing countries.</s></p><p><s>Between 1990 and 2013, age-standardized DALY rates for both sexes decreased by 30% at the global level, by 33% in developed countries, and by 30% in developing countries (web table <ref type="table">9</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Trends in Incidence for Less Common Cancers</head><p><s>As detailed in web table 7, ASIRs per 100 000 for both sexes increased substantially between 1990 and 2013 for certain cancers.</s><s>Kidney cancer ASIRs, for example, increased for both sexes by 23% (from 3.82 to 4.7).</s><s>Rates in developing countries were lower than in developed countries but the relative increase was similar: 34% increase in developing countries (from 1.69 to 2.27) and 36% increase in developed countries (from 7.15 to 9.71).</s></p><p><s>For thyroid cancer, ASIRs per 100 000 on a global scale for both sexes increased by 20% (from 2.74 to 3.3), with a larger relative increase in developing countries (33%; from 2.06 to 2.74) than in <ref type="bibr">developed countries (19%; from 4.16 to 4.95)</ref>.</s></p><p><s>Mesothelioma ASIRs per 100 000 increased by 15% for both sexes globally (from 0.48 to 0.55), with a larger relative increase in developing countries of 26% (from 0.31 to 0.39) compared with a 14% increase in developed countries (from 0.7 to 0.8).</s></p><p><s>Pancreatic cancer ASIRs per 100 000 have increased globally for both sexes by 9% <ref type="bibr">(5.31 to 5.78</ref>) with a larger relative increase in developing (29% from 2.84 to 3.66) compared with developed countries (10% from 8.6 to 9.54).</s></p><p><s>For other cancers, rates substantially decreased between 1990 and 2013.</s><s>Globally, ASIRs per 100 000 for both sexes for gallblad-</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Developing countries</head><p><s>The On a global scale, nasopharynx cancer ASIRs per 100 000 decreased for both sexes by 25% (from 1.64 to 1.23), with a smaller decrease of 27% in developing countries (from 2.07 to 1.52) compared with a 46% decrease in developed countries (from 0.79 to 0.43).</s></p><p><s>Hodgkin lymphoma ASIRs per 100 000 for both sexes decreased globally by 34% (from 2.02 to 1.33), with a larger 37% decrease in developing countries (from 1.9 to 1.2) compared with a 19% decrease in developed countries (from 2.31 to 1.87).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Descriptive cancer epidemiology has a long tradition and has influenced research and policy alike.</s><s>Trends in cancer incidence are especially informative from both a health systems and a scientific perspective.</s><s>They can help with resource allocation planning as a window into the future, and they can be hypothesis generating with regard to the driving factors behind changes.</s><s>The GBD provides a unique source for data on cancer for 3 reasons: (1) a standardized statistical framework has been used to analyze both cancer registry data and cause of death data by country and over time; <ref type="bibr" target="#b43">(2)</ref> in addition to incidence and mortality, other metrics such as DALYs have been used to quantify health loss; and (3) the burden caused by an individual disease can be placed in the context of other diseases or injuries, which is sine qua non to inform health policy and resource allocation decisions.</s></p><p><s>The estimates presented in this study reveal remarkable differences in trends between cancers.</s><s>On a global level between 1990 and 2013, incident cases for every cancer increased (increases ranging from 9% for cervical cancer to 217% for prostate cancer) except for Hodgkin lymphoma, for which incidence has decreased by 10% (from 103 000 to 93 000).</s><s>Since the risk for most cancers increases with age, it is not surprising that aging contributed between 20% and 43% to the absolute increase in incident cases between 1990 and 2013 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>With life expectancy increasing globally, the future burden of cancer will likely increase, unless incidence rates fall substantially. 1 An example of such dramatically decreasing incidence rates from the present study is cervical cancer; incidence rates in this disease decreased by 59% between 1990 and 2013, which led to only a 8.5% increase in incident cases.</s><s>In contrast, the increase in incident cervical cancer cases would have been 67% if incidence rates had remained constant.</s><s>Additional examples of countervailing trends include cancers more common in younger age groups like Hodgkin lymphoma, leukemia, testicular cancer, and brain and nervous system cancer, where population aging does not contribute to an increase in incident cases.</s></p><p><s>Of special concern are the increasing incidence rates in cancers that are also more common in older age groups, since this combination leads to the largest increase in incident cases.</s><s>Prostate cancer, NHL, thyroid cancer, breast cancer, mesothelioma, colon and rectum cancer, and pancreatic cancer all fall into this category.</s><s>Prostate cancer cases increased by 217% between 1990 and 2013 on a global scale, by 169% in developed countries, and by 361% in developing countries.</s><s>Population aging has contributed a larger proportion to this increase in developing countries vs developed countries (54% vs 39%) (eTable 16 in the Supplement), which is not surprising, given the faster rise in life expectancy in developing countries.</s><s>However, 265% of the 361% increase in incidence numbers is due to an increase in age-specific incidence rates.</s><s>It is unclear how much of the overall increase can be attributed to ascertainment bias, but it is unlikely that this would fully explain such a substantial increase in developing countries, given that screening for prostate cancer is not widely practiced in lowand middle-income countries.</s></p><p><s>Between 1990 and 2013, kidney cancer cases for both sexes increased by 107%, with equal contribution from aging populations and increasing incidence rates.</s><s>Incidence rates are still over 4-fold lower in developing countries than in developed countries but with a surprisingly similar relative increase in ASIRs (34% in developing countries, 36% in developed countries).</s><s>This is an exception to most other cancers for which relative changes in trends show a marked difference by development status.</s><s>Many potential risk factors for kidney cancer have been described in the literature, including smoking, obesity, hypertension, and occupational exposures. 27-30</s><s>One possible explanation for the similar trend in incidence rates between developing and developed countries is that even though single risk factors for kidney cancer differ by development status, the overall risk factor pattern might compensate for this disparity.</s><s>Thyroid cancer is another example of a cancer with an alarming rise in incidence.</s><s>For both sexes, incident cases almost doubled between 1990 and 2013 (95% increase).</s><s>Population growth, aging, and increasing rates contributed similar proportions to this increase.</s><s>However, while ASIRs increased globally by 20%, ASDRs decreased by 19% (web table <ref type="table">8</ref>).</s><s>This finding supports the previously recognized notion that at least part of the "thyroid cancer epidemic" can be attributed to overdiagnosis due to the increased use of imaging examinations. 31-33</s><s> In contrast to the group of cancers where rising incidence rates contribute substantially to the increase in absolute cases are the group of cancers with decreasing rates.</s><s>Population growth and aging still result in a larger number of cases in 2013 compared with 1990, but part of this increase is offset by falling rates.</s><s>At the global level, Hodgkin lymphoma and cervical, stomach, larynx, nasopharynx, gallbladder and biliary tract, esophageal, and bladder cancer fall into this group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Focusing on Cancer Prevention</head><p><s>Obviously the interpretation of trends simplifies substantial differences between and within regions and countries as well as between age groups.</s><s>The estimates are therefore also provided at the country level, by age and sex groups.</s><s>However, the description of patterns by development status or region can help correct misconceptions.</s><s>Cancer has long been regarded as a problem of economically developed countries, with the reasoning that cancer burden is substantially higher in affluent countries and that cancer care requires too many resources and is too complex to provide in less developed countries.</s><s>The lack of focus on cancer and other NCDs is highlighted by the Millennium Development Goals (MDGs), 34 which do not include any NCDs.</s><s>However, even though the total 2013 ASIR per 100 000 for cancer was 1.7 times higher in developed regions vs developing regions (328 vs 190), death rates per 100 000 were only 1.2 times higher (148 vs 123).</s><s>Between 1990 and 2013, ASIRs increased in most countries (Figure <ref type="figure">2A</ref>), including developing countries, where the existing health care systems are already overwhelmed by the burden of communicable diseases.</s><s>This rise in cancer incidence has been attributed to increased life expectancy and an increasing prevalence of risk factors like overweight and obesity, smoking, alcohol consumption, and hypertension. 1,35-37</s><s>To avoid an NCD epidemic that could reverse health care advances already achieved in reducing the burden of communicable disease, cancer prevention efforts must be a priority.</s></p><p><s>Tracheal, bronchus, and lung cancer, cervical cancer, and liver cancer are good examples in this aspect.</s><s>Currently, TBL cancer ASIRs for men in regions with low smoking prevalence like sub-Saharan Africa (except southern sub-Saharan Africa) are 5 to 10 times lower than in countries with historically high smoking prevalence like highincome North America, Europe, and east Asia.</s><s>For women, the difference is even more striking, with a 15-fold difference in 2013 ASIRs per 100 000 between western sub-Saharan Africa and highincome North America <ref type="bibr">(2.76 vs 41.8)</ref>, and it is critical that public health efforts ensure that smoking rates remain low in the future. 38,39</s><s> However, smoking is only 1 risk factor for TBL cancer.</s><s>East Asian women have the third highest ASIR for TBL cancer (23 per 100 000), behind high-income North America (42 per 100 000) and Australasia (25 per 100 000), even though smoking rates are substantially lower for women in east Asia than they are in other countries with similar incidence rates. 38</s><s>Genetic susceptibility might play a role, but preventable risk factors like household air pollution have also been identified as a reason behind this unusual pattern. 40-44</s><s> Cervical cancer rates in regions with screening programs, like Australasia, high-income North-America, Western Europe, and highincome Asia Pacific, are below 10 per 100 000, whereas rates are up to 3 times as high in countries without screening programs (29 per 100 000 in Andean Latin America, 30 per 100 000 in western sub-Saharan Africa, and 58 per 100 000 in Oceania).</s><s>It is encouraging that between 1990 and 2013, cervical cancer ASIRs decreased in all regions between 8% and 47% (web table 1).</s><s>However, in 2013, cervical cancer, a preventable and treatable cancer, remains the cancer with the highest incidence in women in 27 countries and the leading cause of cancer death in women in 45 countries.</s><s>Efforts to determine the most cost-effective strategies to reduce cervical cancer burden through human papillomavirus vaccination and screening are ongoing and will hopefully lead to a continued decrease in cervical cancer incidence in the most affected areas of the world. 45-50</s><s> Liver cancer ranks second for mortality in developing countries.</s><s>Treatment for liver cancer is not very effective, with 2013 ASIRs and ASDRs per 100 000 being very similar in both developing and developed countries <ref type="bibr">(ASIRs,</ref><ref type="bibr">14.72 and 7.42,</ref><ref type="bibr">respectively;</ref><ref type="bibr">ASDRs,</ref><ref type="bibr">15.59 and 7.26,</ref><ref type="bibr">respectively)</ref>.</s><s>The main risk factors for liver cancer are hepatitis B infection, hepatitis C infection, and chronic hepatitis and cirrhosis due to alcohol and other causes. 51-56</s><s>In 2013, of the 818 000 deaths in men and women, 300 000 (37%) were estimated to be due to hepatitis B infection, 343 000 (42%) due to hepatitis C infection, 92 000 (11%) due to alcohol abuse, and 83 000 (10%) due to other causes. 1 Hepatitis B vaccination has proven cost-effective in preventing liver cancer due to hepatitis B, and treatment for hepatitis C, although expensive, has recently shown success. 57,58</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Limitations</head><p><s>The core components of the GBD cancer estimates are cancer registry and vital registry data.</s><s>However, these sources are sparse in many low-and middle-income countries, and in the absence of data, the estimates are dependent on covariate selection and regional patterns.</s><s>This is accounted for by estimating uncertainty intervals (provided for all estimates in eTables in the Supplement).</s><s>Even though cancer registry data are considered the gold standard for cancer surveillance, the quality of registries can vary substantially.</s><s>Underreporting of cancer cases or deaths or a high proportion of undefined codes can lead to cancer registry data that do not represent the true cancer burden. 59-62</s><s>As described in the Methods section, our analysis is therefore heavily based on cause-of-death data and to a lesser degree on cancer registry data.</s><s>This explains why the estimates reported might be different from cancer registry data.</s><s>To ensure consistency, robustness, and clarity in this framework, the same estimation methods were used for all cancers, as well as advanced modeling techniques like ensemble models with a large pool of covariates and out-of-sample validation.</s><s>The benefit of estimating the different cancers within the GBD framework is that it ensures that cancer estimates are adjusted to be consistent with the all-cause mortality estimates, preventing inflation or underestimation of causespecific estimates.</s><s>A detailed description of these methods is provided in the eAppendix in the Supplement.</s><s>While quite advanced, these methodologies still result in only estimates, which should be used as placeholders until high-quality data become available.</s><s>Hopefully, the newly launched Global Initiative for Cancer Registry Development, 63 an effort to expand cancer registries in low-and middle-income countries, will lead to improved data availability and quality in these countries.</s></p><p><s>Underreporting of new cancer cases to cancer registries or miscoding cause of death can lead to MI ratios that are either too low or too high. 64,65</s><s>Miscoding is especially common in countries with limited diagnostic resources and arises when metastatic lesions are coded as primary cancers, which can lead to overestimation of primary cancers in anatomic sites where metastases are often found (eg, liver or brain).</s><s>Also, increasing incidence rates with stable mortality rates can lead to an underestimation of MI ratios, and decreasing incidence rates with stable mortality rates can lead to MI ratios higher than 1.</s><s>These factors can result in seemingly implausible estimates like higher estimates for cancer deaths compared with cancer incident cases in the same year.</s><s>Changing classification systems (eg, from ICD-9 Basic Tabulation List to ICD-9 detail) can also lead to substantial changes in estimates over time.</s><s>To improve the quality of the data sources and to ensure comparability, garbage codes or undefined cancer codes were redistributed , and different coding systems were mapped to a set of uniform GBD causes.</s></p><p><s>To estimate YLDs, MI ratios were used as surrogates for cancer survival owing to lack of high-quality survival data in most countries.</s><s>Using MI ratios as a surrogate for survival is problematic because of the different patient cohorts with changing survival probabilities that are captured in the mortality numerator.</s><s>The approach taken in the present analysis, therefore, was to use MI ratios as a surrogate for access to care, which avoids the problem with "backscattering" of different cohorts. 66</s><s>However, survival data remain the gold standard, and availability of survival data has increased with the recently published CONCORD-2 study, 4 which provides survival estimates for 67 countries.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>Cancer was the second leading cause of death in 2013 after cardiovascular disease (eFigure 5a in the Supplement), and cancer burden as part of the NCDs is expected to increase in all countries due to population growth, aging, and an increasing prevalence of certain risk factors. 1 The health community has responded to this global health threat through endorsing the "25 by 25" strategy as part of the NCD Global Monitoring Framework during the World Health Assembly in 2012, 67 with the goal of reducing avoidable mortality from NCDs by 25% by 2025.</s><s>This is a challenging goal and will require commitment from all levels of society.</s><s>Populationlevel observations of cancer burden and time trends as presented herein help highlight aspects of cancer epidemiology that can guide intervention programs and advance research in cancer determinants and outcomes.</s></p><p><s>Cancer control strategies have to be prioritized based on local needs, and current data on cancer burden will be necessary for the development of national NCD action and cancer control plans.</s><s>In acknowledgment of this need, annual updates of the burden of cancer will be published.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Box 1 .Figure 2 .Figure 3 .Figure 4 . 2013 Figure 5 .Figure 6 .Figure 7 .Figure 8 .Figure 9 .Figure 10 .Figure 11 .Figure 12 .Figure 13 .Figure 14 .Figure 15 .</head><label>1234201356789101112131415</label><figDesc><div><p><s>Figure 1.</s><s>Age-Specific Global Contributions of Cancer Types to Total Cancer Incidence and Mortality, 2013Figure 2. Relative Changes in Age-Standardized Incidence and Death Rates in Both Sexes for All Cancers Except NMSC and KS in 188 Countries From 1990 to 2013 Figure 3. Cancers Ranked by Numbers of Incident Cases in Both Sexes, Globally, by Development Status, and in the 50 Most Populous Countries, 2013Figure 4. Cancers Ranked by Numbers of Deaths in Both Sexes, Globally, by Development Status, and in the 50 Most Populous Countries, 2013 Figure 5. Cancers Ranked Globally and for Both Sexes by Absolute Years of Life Lost (YLLs) Including the Percentage Change in Absolute YLLs and the Percentage Change in the Age-Standardized YLL Rate Between 1990 and 2013 Figure 6.</s><s>Trends in Age-Standardized Incidence Rates for Tracheal, Bronchus, and Lung Cancer, 1990-2013 Figure 7. Trends in Age-Standardized Incidence Rates for Female Breast Cancer, 1990-2013 Figure 8. Trends in Age-Standardized Incidence Rates for Colon and Rectum Cancer, 1990-2013 Figure 9. Trends in Age-Standardized Incidence Rates for Prostate Cancer, 1990-2013 Figure 10.</s><s>Trends in Age-Standardized Incidence Rates for Stomach Cancer, 1990-2013 Figure 11.</s><s>Trends in Age-Standardized Incidence Rates for Liver Cancer, 1990-2013 Figure 12.</s><s>Trends in Age-Standardized Incidence Rates for Cervical Cancer, 1990-2013 Figure 13.</s><s>Trends in Age-Standardized Incidence Rates for Non-Hodgkin Lymphoma, 1990-2013 Figure 14.</s><s>Trends In Age-Standardized Incidence Rates for Esophageal Cancer, 1990-2013 Figure 15.</s><s>Trends in Age-Standardized Incidence Rates forLeukemia, 1990Leukemia,  -2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Age-Specific Global Contributions of Cancer Types to Total Cancer Incidence and Mortality, 2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. Cancers Ranked Globally and for Both Sexes by Absolute Years of Life Lost (YLLs) Including the Percentage Change in Absolute YLLs and the Percentage Change in the Age-Standardized YLL Rate Between 1990 and 2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 6 .</head><label>6</label><figDesc><div><p><s>Figure 6.</s><s>Trends in Age-Standardized Incidence Rates for Tracheal, Bronchus, and Lung Cancer, 1990-2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 8 .Figure 9 .Age</head><label>89</label><figDesc><div><p><s>Figure 8. Trends in Age-Standardized Incidence Rates for Colon and Rectum Cancer, 1990-2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 10 .</head><label>10</label><figDesc><div><p><s>Figure 10.</s><s>Trends in Age-Standardized Incidence Rates for Stomach Cancer, 1990-2013 Stomach cancer</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 11 .Figure 12 .Age</head><label>1112</label><figDesc><div><p><s>Figure 11.</s><s>Trends in Age-Standardized Incidence Rates for Liver Cancer, 1990-2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 13 .</head><label>13</label><figDesc><div><p><s>Figure 13.</s><s>Trends in Age-Standardized Incidence Rates for Non-Hodgkin Lymphoma, 1990-2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Figure 14 .</head><label>14</label><figDesc><div><p><s>Figure 14.</s><s>Trends in Age-Standardized Incidence Rates for Esophageal Cancer, 1990-2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 15 .</head><label>15</label><figDesc><div><p><s>Figure 15.</s><s>Trends in Age-Standardized Incidence Rates forLeukemia, 1990Leukemia,  -2013</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Incidence and Deaths for All Cancers and 28 Cancer Groups</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc></figDesc><table><row><cell>eTable 5. Countries within GBD regions</cell></row><row><cell>eTable 6. Countries by development status</cell></row><row><cell>eTable 7. Results of regression analysis for undefined malignant</cell></row><row><cell>neoplasms of the lip, oral cavity and pharynx (C14) by age group and</cell></row><row><cell>region, male</cell></row><row><cell>eTable 8. Carcinoma in situ, neoplasm of uncertain behavior</cell></row><row><cell>and benign neoplasm assigned to GBD cancer in CoD</cell></row><row><cell>redistribution</cell></row><row><cell>eTable 9. Increase in mortality after redistributing benign, in situ</cell></row><row><cell>neoplasms or neoplasms of uncertain behavior to respective cancer</cell></row><row><cell>by different years and ICD coding system</cell></row><row><cell>eTable 10. Increase in mortality estimates for the year 2008 after</cell></row><row><cell>redistribution of different categories of garbage code for all</cell></row><row><cell>countries using ICD-10 in 2008</cell></row><row><cell>eTable 11. Covariates selected for CODEm for each GBD cancer</cell></row><row><cell>group</cell></row><row><cell>eTable 12. Results for CODEm model testing</cell></row><row><cell>eTable 13. Sources of procedure sequelae data</cell></row><row><cell>eTable 14. Reference life expectancy</cell></row><row><cell>eTable 15. ICD-10 codes for "other cancer" group</cell></row><row><cell>eTable 16a. Decomposition of trends in incidence, developed</cell></row><row><cell>countries, both sexes, 1990 to 2013</cell></row></table><note><p><s>. Decomposition Analysis of Cancer Trends in Global Incidence, Both Sexes, 1990 to 2013 eTable 1.</s><s>Sources for cancer incidence and MI ratio data by country and registry eTable 2. Number of site years for cause of death data by source eTable 3. List of International Classification of Diseases (ICD) codes mapped to the Global Burden of Disease cause list for cancer eTable 4. Undefined cancer code categories (ICD-10) and respective target codes for cancer registry incidence data eTable 16b.</s><s>Decomposition of trends in incidence, developing countries, both sexes, 1990 to 2013 eTable 17.</s><s>Probability of developing cancer within selected age intervals, global, by sex, 2010-2013</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc><div><p><s>Top 10 Cancers (Ranked by the Highest Number of Incident Cases Globally in 2013)</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>2013 Incidence and Deaths for All Cancers and 28 Cancer Groups a</s></p></div></figDesc><table><row><cell></cell><cell cols="3">Incident Cases, Global</cell><cell cols="2">ASIR, Both Sexes</cell><cell></cell><cell cols="2">Deaths, Global</cell><cell></cell><cell cols="2">ASDR, Both Sexes</cell><cell></cell></row><row><cell></cell><cell cols="2">(Thousands)</cell><cell></cell><cell>(per 100 000)</cell><cell></cell><cell></cell><cell cols="2">(Thousands)</cell><cell></cell><cell>(per 100 000)</cell><cell></cell><cell></cell></row><row><cell>Cancer</cell><cell>Total</cell><cell>Male</cell><cell cols="5">Female Developing Developed Global Total</cell><cell>Male</cell><cell cols="4">Female Developing Developed Global</cell></row><row><cell>All except NMSC</cell><cell>14 943</cell><cell>8048</cell><cell>6894</cell><cell>190.4</cell><cell>327.9</cell><cell cols="2">237.4 8196</cell><cell>4723</cell><cell>3473</cell><cell>123.0</cell><cell>147.9</cell><cell>133.1</cell></row><row><cell>and KS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Esophageal</cell><cell>442</cell><cell>309</cell><cell>133</cell><cell>8.9</cell><cell>3.9</cell><cell>7.1</cell><cell>440</cell><cell>308</cell><cell>132</cell><cell>9.1</cell><cell>3.8</cell><cell>7.2</cell></row><row><cell>Stomach</cell><cell>984</cell><cell>630</cell><cell>354</cell><cell>16.9</cell><cell>14.4</cell><cell>16.1</cell><cell>841</cell><cell>530</cell><cell>311</cell><cell>15.3</cell><cell>11.1</cell><cell>13.8</cell></row><row><cell>Liver</cell><cell>792</cell><cell>559</cell><cell>233</cell><cell>14.7</cell><cell>7.4</cell><cell>12.5</cell><cell>818</cell><cell>564</cell><cell>254</cell><cell>15.6</cell><cell>7.3</cell><cell>13.0</cell></row><row><cell>Larynx</cell><cell>177</cell><cell>155</cell><cell>22</cell><cell>2.8</cell><cell>2.9</cell><cell>2.8</cell><cell>88</cell><cell>75</cell><cell>12</cell><cell>1.5</cell><cell>1.3</cell><cell>1.4</cell></row><row><cell>Tracheal, bronchus</cell><cell>1798</cell><cell>1263</cell><cell>535</cell><cell>25.2</cell><cell>37.7</cell><cell cols="2">29.4 1640</cell><cell>1155</cell><cell>485</cell><cell>24.1</cell><cell>32.9</cell><cell>27.0</cell></row><row><cell>and lung</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Breast</cell><cell>1804</cell><cell>25</cell><cell>1779</cell><cell>21.0</cell><cell>40.8</cell><cell>27.4</cell><cell>471</cell><cell>7</cell><cell>464</cell><cell>5.9</cell><cell>10.1</cell><cell>7.4</cell></row><row><cell>Cervical</cell><cell>485</cell><cell>…</cell><cell>485</cell><cell>8.0</cell><cell>5.0</cell><cell>7.1</cell><cell>236</cell><cell>…</cell><cell>236</cell><cell>4.3</cell><cell>2.2</cell><cell>3.6</cell></row><row><cell>Uterine</cell><cell>353</cell><cell>…</cell><cell>353</cell><cell>4.2</cell><cell>7.7</cell><cell>5.4</cell><cell>68</cell><cell>…</cell><cell>68</cell><cell>0.9</cell><cell>1.4</cell><cell>1.1</cell></row><row><cell>Prostate</cell><cell>1442</cell><cell>1442</cell><cell>…</cell><cell>14.3</cell><cell>43.2</cell><cell>24.3</cell><cell>293</cell><cell>293</cell><cell>…</cell><cell>3.6</cell><cell>7.4</cell><cell>5.2</cell></row><row><cell>Colon and rectum</cell><cell>1573</cell><cell>873</cell><cell>700</cell><cell>16.3</cell><cell>42.3</cell><cell>25.8</cell><cell>771</cell><cell>414</cell><cell>357</cell><cell>9.4</cell><cell>18.2</cell><cell>12.8</cell></row><row><cell>Lip and oral cavity</cell><cell>409</cell><cell>275</cell><cell>134</cell><cell>6.7</cell><cell>6.0</cell><cell>6.4</cell><cell>135</cell><cell>87</cell><cell>48</cell><cell>2.3</cell><cell>1.9</cell><cell>2.1</cell></row><row><cell>Nasopharynx</cell><cell>84</cell><cell>62</cell><cell>22</cell><cell>1.5</cell><cell>0.4</cell><cell>1.2</cell><cell>60</cell><cell>43</cell><cell>17</cell><cell>1.2</cell><cell>0.3</cell><cell>0.9</cell></row><row><cell>Other pharynx</cell><cell>140</cell><cell>117</cell><cell>22</cell><cell>2.0</cell><cell>2.6</cell><cell>2.1</cell><cell>79</cell><cell>63</cell><cell>16</cell><cell>1.3</cell><cell>1.2</cell><cell>1.2</cell></row><row><cell>Gallbladder and</cell><cell>186</cell><cell>79</cell><cell>107</cell><cell>2.5</cell><cell>3.8</cell><cell>3.1</cell><cell>140</cell><cell>54</cell><cell>86</cell><cell>2.0</cell><cell>2.7</cell><cell>2.3</cell></row><row><cell>biliary tract</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Pancreatic</cell><cell>350</cell><cell>184</cell><cell>166</cell><cell>3.7</cell><cell>9.5</cell><cell>5.8</cell><cell>352</cell><cell>185</cell><cell>167</cell><cell>3.7</cell><cell>9.6</cell><cell>5.9</cell></row><row><cell>Malignant skin melanoma</cell><cell>272</cell><cell>143</cell><cell>130</cell><cell>1.5</cell><cell>10.8</cell><cell>4.2</cell><cell>57</cell><cell>32</cell><cell>25</cell><cell>0.4</cell><cell>1.9</cell><cell>0.9</cell></row><row><cell>Ovarian</cell><cell>226</cell><cell>…</cell><cell>226</cell><cell>2.4</cell><cell>5.6</cell><cell>3.5</cell><cell>158</cell><cell>…</cell><cell>158</cell><cell>1.8</cell><cell>3.7</cell><cell>2.5</cell></row><row><cell>Testicular</cell><cell>59</cell><cell>59</cell><cell>…</cell><cell>0.6</cell><cell>1.8</cell><cell>0.8</cell><cell>8</cell><cell>8</cell><cell>…</cell><cell>0.1</cell><cell>0.1</cell><cell>0.1</cell></row><row><cell>Kidney</cell><cell>295</cell><cell>195</cell><cell>99</cell><cell>2.3</cell><cell>9.7</cell><cell>4.7</cell><cell>134</cell><cell>87</cell><cell>47</cell><cell>1.3</cell><cell>3.7</cell><cell>2.2</cell></row><row><cell>Bladder</cell><cell>401</cell><cell>312</cell><cell>89</cell><cell>3.2</cell><cell>12.8</cell><cell>6.7</cell><cell>174</cell><cell>130</cell><cell>44</cell><cell>2.4</cell><cell>3.7</cell><cell>3.0</cell></row><row><cell>Brain and nervous system</cell><cell>305</cell><cell>167</cell><cell>137</cell><cell>4.1</cell><cell>5.9</cell><cell>4.5</cell><cell>204</cell><cell>118</cell><cell>86</cell><cell>2.9</cell><cell>3.8</cell><cell>3.1</cell></row><row><cell>Thyroid</cell><cell>226</cell><cell>50</cell><cell>176</cell><cell>2.7</cell><cell>4.9</cell><cell>3.3</cell><cell>34</cell><cell>12</cell><cell>21</cell><cell>0.5</cell><cell>0.6</cell><cell>0.6</cell></row><row><cell>Mesothelioma</cell><cell>34</cell><cell>24</cell><cell>10</cell><cell>0.4</cell><cell>0.8</cell><cell>0.5</cell><cell>34</cell><cell>24</cell><cell>10</cell><cell>0.4</cell><cell>0.8</cell><cell>0.5</cell></row><row><cell>Hodgkin lymphoma</cell><cell>93</cell><cell>56</cell><cell>38</cell><cell>1.2</cell><cell>1.9</cell><cell>1.3</cell><cell>24</cell><cell>14</cell><cell>10</cell><cell>0.4</cell><cell>0.4</cell><cell>0.4</cell></row><row><cell>Non-Hodgkin lymphoma</cell><cell>465</cell><cell>264</cell><cell>202</cell><cell>5.2</cell><cell>11.3</cell><cell>7.3</cell><cell>226</cell><cell>133</cell><cell>92</cell><cell>2.9</cell><cell>4.5</cell><cell>3.6</cell></row><row><cell>Multiple myeloma</cell><cell>117</cell><cell>64</cell><cell>53</cell><cell>1.0</cell><cell>3.5</cell><cell>1.9</cell><cell>79</cell><cell>42</cell><cell>37</cell><cell>0.7</cell><cell>2.3</cell><cell>1.3</cell></row><row><cell>Leukemia</cell><cell>414</cell><cell>243</cell><cell>172</cell><cell>5.1</cell><cell>8.1</cell><cell>6.3</cell><cell>265</cell><cell>149</cell><cell>116</cell><cell>3.5</cell><cell>4.8</cell><cell>4.1</cell></row><row><cell>Other neoplasms</cell><cell>1015</cell><cell>496</cell><cell>518</cell><cell>12.0</cell><cell>23.0</cell><cell>15.7</cell><cell>370</cell><cell>195</cell><cell>175</cell><cell>5.4</cell><cell>6.2</cell><cell>5.8</cell></row><row><cell cols="5">Abbreviations: ASDR, age-standardized death rate; ASIR, age-standardized</cell><cell></cell><cell cols="7">to neoplasms (ICD-9 140-239; ICD-10 C00-D49) except for NMSC and KS.</cell></row><row><cell cols="5">incidence rate; DALYs, disability-adjusted life-years; GBD, Global Burden of</cell><cell></cell><cell cols="7">eTable 3 in the Supplement details how the original ICD codes were mapped to</cell></row><row><cell cols="5">Disease; ICD-9, International Classification of Diseases, Ninth Revision;</cell><cell></cell><cell cols="7">the standardized GBD cause list. 1 Detailed results for incidence, mortality,</cell></row><row><cell cols="5">ICD-10, International Statistical Classification of Diseases and Related Health</cell><cell></cell><cell cols="6">YLDs, YLLs, and DALYs by country development status (developed vs</cell><cell></cell></row><row><cell cols="5">Problems, Tenth Revision; KS, Kaposi sarcoma; NMSC, nonmelanoma skin</cell><cell></cell><cell cols="7">developing), region, and country are reported in web tables 1 through 9. Sums</cell></row><row><cell cols="5">cancer; YLDs, years lived with disability; YLLs, years of life lost.</cell><cell></cell><cell cols="4">might not total precisely due to rounding.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">a Cancer groups are defined based on ICD codes and include all codes pertaining</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head></head><label></label><figDesc><div><p><s>Figure 2. Relative Changes in Age-Standardized Incidence and Death Rates in Both Sexes for All Cancers Except NMSC and KS in 188 Countries From 1990 to 2013 Figure 3. Cancers Ranked by Number of Incident Cases in Both Sexes, Globally, by Development Status, and in the 50 Most Populous Countries, 2013 Figure 4. Cancers Ranked by Number of Deaths in Both Sexes, Globally, by Development Status, and in the 50 Most Populous Countries, 2013</s></p></div></figDesc><table><row><cell cols="2">The Global Burden of Cancer 2013</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Special Communication Clinical Review &amp; Education</cell></row><row><cell cols="2">Incidence rate changes, 1990-2013 Country Country Region A Region</cell><cell>Breast cancer</cell><cell cols="2">Tracheal, bronchus, and lung cancer Tracheal, bronchus, and lung cancer</cell><cell cols="2">Colon and rectum cancer Stomach cancer</cell><cell cols="2">Prostate cancer Liver cancer</cell><cell cols="2">Stomach cancer Colon and rectum cancer</cell><cell cols="2">Liver cancer Breast cancer</cell><cell cols="2">Cervical cancer Esophageal cancer</cell><cell cols="2">Non-Hodgkin lymphoma Pancreatic cancer</cell><cell cols="2">Esophageal cancer Prostate cancer</cell><cell>Leukemia Leukemia</cell><cell>Lip and oral cavity cancer Cervical cancer</cell><cell>Bladder cancer Non-Hodgkin lymphoma</cell><cell>Uterine cancer Brain and nervous system cancer</cell><cell>Pancreatic cancer Bladder cancer</cell><cell>Brain and nervous system cancer Ovarian cancer</cell><cell>Kidney cancer Gallbladder and biliary tract cancer</cell><cell>Malignant skin melanoma Lip and oral cavity cancer</cell><cell>Ovarian cancer Kidney cancer</cell><cell>Thyroid cancer Larynx cancer</cell><cell>Gallbladder and biliary tract cancer Multiple myeloma</cell><cell>Larynx cancer Other pharynx cancer</cell><cell>Esophageal cancer Stomach cancer Liver cancer Larynx cancer Tracheal, bronchus, and lung cancer Breast cancer Other pharynx cancer Multiple myeloma Hodgkin lymphoma Nasopharynx cancer Testicular cancer Uterine cancer Nasopharynx cancer Malignant skin melanoma Mesothelioma Thyroid cancer</cell><cell>Mesothelioma Hodgkin lymphoma</cell><cell>Testicular cancer</cell></row><row><cell>Global Global</cell><cell></cell><cell>1</cell><cell>1</cell><cell>2</cell><cell>2</cell><cell>3</cell><cell>3</cell><cell>4</cell><cell>4</cell><cell>5</cell><cell>5</cell><cell>6</cell><cell>6</cell><cell>7</cell><cell>7</cell><cell>8</cell><cell>8</cell><cell cols="8">Cervical cancer 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 9 10 11 12 13 14 15 16 17 18 19 20 22 23 24 25 26 27</cell></row><row><cell>Developed Developed</cell><cell></cell><cell>3</cell><cell>1</cell><cell>4</cell><cell>3</cell><cell>2</cell><cell>7</cell><cell>1</cell><cell>2</cell><cell cols="16">Uterine cancer 5 11 17 7 20 12 14 6 13 8 16 10 9 15 18 19 22 23 21 24 27 25 26 4 11 5 6 8 17 9 14 10 13 15 18 12 21 16 22 26 19 23 24 25 27</cell></row><row><cell>Developing Developing</cell><cell>Decreased</cell><cell>1</cell><cell>1</cell><cell>2</cell><cell>3</cell><cell>4</cell><cell>2</cell><cell>6</cell><cell>4</cell><cell>3</cell><cell>6</cell><cell>5</cell><cell>5</cell><cell cols="12">Prostate cancer 7 11 8 10 9 16 13 14 12 20 23 18 15 19 17 21 25 24 22 26 27 9 12 8 7 11 10 14 15 16 13 18 17 22 19 20 24 26 23 25 27</cell></row><row><cell cols="26">Cancer Mortality For International Classification of Diseases codes included in the other neoplasms group, see eTable 15 in the Supplement. B Caribbean LCA DMA ATG TTO GRD VCT TLS MDV BRB SYC MUS COM Persian Gulf W Africa E Med. MLT SGP Balkan Peninsula Caribbean LCA DMA ATG TTO GRD VCT TLS MDV BRB SYC MUS COM Persian Gulf W Africa E Med. MLT SGP Balkan Peninsula Death rate changes, 1990-2013 B &gt;10%−20% 0%−10% 0%−10% &gt;10%−20% &gt;20% &gt;20% Increased &gt;10%−20% 0%−10% 0%−10% &gt;10%−20% &gt;20% &gt;20% Decreased Increased ATG indicates Antigua and Barbuda; BRB, Barbados; COM, Comoros; DMA, Dominica; E Med: Eastern Mediterranean; FJI, Fiji; FSM, Federated States of Micronesia; GRD, Grenada; KIR, Kiribati; KS, Kaposi sarcoma; LCA, Saint Lucia; MDV, Maldives; MLT, Malta; MUS, Mauritius; MHL, Marshall Islands; NMSC, nonmelanoma skin cancer; SGP, Singapore; SLB, Solomon Islands; Colon and rectum cancer Lip and oral cavity cancer Nasopharynx cancer Other pharynx cancer Gallbladder and biliary tract cancer Pancreatic cancer Malignant skin melanoma Ovarian cancer Testicular cancer Kidney cancer Bladder cancer Brain and nervous system cancer Thyroid cancer Mesothelioma Hodgkin lymphoma Non-Hodgkin lymphoma Multiple myeloma Leukemia Other neoplasms TON WSM FSM KIR FJI VUT SLB MHL TON WSM FSM KIR FJI VUT SLB MHL SYC, Seychelles; TLS, Timor-Leste; TON, Tonga; TTO, Trinidad and Tobago; VCT, Saint Vincent and the Grenadines; VUT, Vanuatu; W Africa, West Africa; WSM, Samoa. jamaoncology.com South Korea Canada United States Argentina a France Germany Italy Spain United Kingdom Uzbekistan a Poland Russia Ukraine Peru a Colombia a Mexico a Venezuela a Brazil a China a North Korea a Indonesia a Malaysia a Myanmar a Philippines a Thailand a Vietnam a Afghanistan a Bangladesh a India a Nepal a Pakistan a Algeria a Egypt a Iran a Iraq a Morocco a Saudi Arabia a Sudan a Turkey a Yemen a DRC a,b Ethiopia a Kenya a Mozambique a Tanzania a Uganda a High-income Asia Pacific High-income North America Southern Latin America Western Europe Central Asia Central Europe Eastern Europe Andean Latin America Central Latin America Tropical Latin America East Asia Southeast Asia South Asia North Africa and Middle East Central sub-Saharan Africa Eastern sub-Saharan Africa South Africa a Ghana a Southern sub-Saharan Africa Western sub-Saharan Africa 4 2 1 6 3 5 17 10 11 13 14 9 18 7 22 12 23 15 16 8 21 20 19 27 26 25 24 5 2 1 8 3 4 13 10 15 14 18 11 19 9 16 12 23 17 6 7 21 22 20 25 24 27 26 4 3 2 1 12 18 20 5 19 10 14 6 8 11 13 9 7 15 17 21 22 23 16 24 27 25 26 2 3 4 1 13 18 20 7 19 11 12 6 9 10 17 8 5 15 14 23 21 22 16 24 27 25 26 1 4 3 2 5 18 6 8 14 12 16 10 7 9 19 11 15 17 21 13 20 25 23 24 26 22 27 3 4 2 1 10 14 19 6 18 13 12 5 7 11 16 9 8 17 22 23 21 15 20 24 27 25 26 3 4 2 1 6 16 21 9 18 11 15 5 12 8 14 7 10 13 22 17 23 19 20 26 27 24 25 2 4 1 3 6 8 21 7 22 11 19 5 12 9 14 10 13 15 18 16 20 24 17 25 27 26 23 4 3 1 2 6 11 20 7 23 12 13 5 8 9 15 10 14 16 22 19 17 21 18 24 27 25 26 4 3 2 1 7 18 19 6 12 11 17 5 14 9 15 10 8 13 24 23 20 22 16 26 27 25 21 1 3 8 11 2 9 4 12 5 6 10 20 13 16 7 17 18 19 24 21 14 23 25 15 26 22 27 3 1 2 4 6 19 11 14 20 12 16 5 9 8 13 7 17 10 21 18 15 23 22 25 26 24 27 3 2 1 5 4 17 9 14 19 12 11 8 10 7 18 6 16 13 15 21 20 22 24 23 26 25 27 2 3 1 4 5 21 9 15 20 11 8 10 17 7 14 6 13 12 16 19 18 22 24 23 27 26 25 3 6 4 1 2 9 5 7 21 8 18 20 10 12 15 14 17 16 11 13 24 25 19 23 27 22 26 2 6 4 1 3 10 5 9 17 7 16 23 13 12 11 20 18 14 8 15 19 25 22 21 26 24 27 2 7 3 1 5 10 4 9 22 8 18 24 16 12 14 11 20 13 6 17 19 25 23 21 27 15 26 2 4 5 1 6 13 3 7 19 8 16 22 10 11 17 12 20 15 9 18 14 25 21 23 26 24 27 2 4 3 1 5 17 6 11 14 8 10 21 16 12 7 18 13 20 9 22 15 19 23 24 26 25 27 5 1 4 9 2 3 12 11 6 8 19 14 7 13 10 20 26 21 17 18 16 25 24 22 15 27 23 4 1 5 11 3 2 7 12 6 9 14 17 8 13 10 22 23 21 20 19 16 25 24 18 15 27 26 1 2 4 7 5 10 3 8 21 11 6 18 13 15 12 19 23 14 9 16 20 22 25 24 17 26 27 1 2 3 4 7 6 10 5 19 8 14 15 12 17 18 16 22 11 9 23 20 21 25 24 13 26 27 1 2 5 11 12 4 3 9 17 7 6 22 8 15 14 23 24 10 13 16 19 20 25 21 18 26 27 1 2 4 3 12 7 5 11 23 6 10 20 9 15 14 18 21 13 8 19 17 22 26 25 16 24 27 3 1 4 5 7 2 6 10 19 11 8 13 17 16 14 18 23 15 12 9 20 21 26 25 22 24 27 4 2 5 12 3 1 8 6 10 11 7 18 13 17 9 21 25 20 14 19 15 16 26 24 22 23 27 3 2 8 10 1 9 4 12 17 5 14 11 13 18 6 20 23 22 16 21 15 25 24 7 19 26 27 3 4 7 11 6 2 8 5 10 9 1 19 17 22 14 23 24 12 26 18 15 13 25 20 16 21 27 1 6 4 15 5 8 3 11 7 10 2 19 24 22 12 21 16 14 17 20 13 9 25 18 23 26 27 1 4 6 13 7 9 3 12 5 8 2 21 22 17 14 23 25 11 20 16 15 10 24 18 19 26 27 1 3 6 8 13 12 15 5 4 7 2 9 17 24 14 22 25 11 18 20 10 16 23 19 21 26 27 1 3 2 10 4 15 7 6 23 5 21 14 20 16 8 22 24 17 12 9 18 25 19 13 11 26 27 1 6 7 3 9 2 11 13 20 4 14 8 15 10 5 16 23 19 12 18 17 24 25 22 26 21 27 2 5 6 3 1 9 15 10 4 7 14 12 24 17 8 18 21 19 13 16 11 26 23 20 25 22 27 1 2 5 8 6 7 10 11 19 3 15 14 9 12 4 16 26 17 13 20 18 24 23 21 25 22 27 1 2 6 3 5 9 4 10 20 8 13 15 11 12 7 21 23 17 16 14 19 25 26 18 22 24 27 1 4 2 6 9 3 16 5 17 8 13 14 22 11 7 15 26 18 10 12 19 21 23 24 25 20 27 1 2 4 5 3 8 11 9 15 6 14 10 18 17 7 19 22 20 12 21 16 26 24 13 23 25 27 2 1 3 4 5 13 18 7 24 6 20 10 11 9 8 16 22 14 12 19 15 27 21 23 25 17 26 1 2 5 8 3 9 6 10 19 4 15 11 12 18 7 22 23 20 13 16 17 26 24 14 21 25 27 1 7 5 3 4 6 2 9 8 11 10 16 17 15 12 19 14 20 24 18 21 23 22 13 25 26 27 1 8 4 3 7 6 2 9 5 18 11 21 15 16 10 12 13 19 22 17 25 24 20 14 26 23 27 1 10 5 4 6 9 3 8 2 14 7 15 23 13 12 20 18 11 17 24 16 25 19 21 22 26 27 2 7 4 1 5 6 3 8 10 14 11 19 18 16 9 13 15 20 25 17 24 23 21 12 26 22 27 1 10 4 2 8 5 3 7 6 14 11 21 18 17 9 13 15 19 23 16 25 24 20 12 26 22 27 3 9 6 1 8 7 2 4 5 12 11 16 15 19 21 18 20 10 13 25 24 22 23 14 17 26 27 2 4 3 1 10 11 6 7 5 13 8 15 14 9 21 17 12 16 20 23 18 22 19 24 27 25 26 3 10 5 1 6 4 2 8 13 12 17 15 7 9 11 20 19 14 21 18 25 26 22 16 24 23 27 Japan South Korea Canada United States Argentina a France Germany Italy Spain United Kingdom Uzbekistan a Poland Russia Ukraine Peru a Colombia a Mexico a Venezuela a Brazil a China a North Korea a Indonesia a Malaysia a Myanmar a Philippines a Thailand a Vietnam a Afghanistan a Bangladesh a India a Nepal a Pakistan a Algeria a Egypt a Iran a Iraq a Morocco a Saudi Arabia a Sudan a Turkey a Yemen a DRC a,b Ethiopia a Kenya a Mozambique a Tanzania a Uganda a High-income Asia Pacific High-income North America Southern Latin America Western Europe Central Asia Central Europe Eastern Europe Andean Latin America Central Latin America Tropical Latin America East Asia Southeast Asia South Asia North Africa and Middle East Central sub-Saharan Africa Eastern sub-Saharan Africa South Africa a Ghana a Southern sub-Saharan Africa Western sub-Saharan Africa 1 2 4 3 9 7 5 8 11 16 10 18 12 14 6 17 13 23 15 19 24 25 22 21 26 27 1 3 2 4 8 7 5 9 11 13 10 14 12 16 6 20 15 18 17 21 24 23 25 19 26 27 1 7 13 2 3 12 5 4 8 20 6 9 10 11 17 18 14 22 15 23 25 16 21 24 26 27 1 9 8 2 3 13 4 5 7 18 6 12 14 10 20 19 11 21 15 22 26 16 23 24 25 27 1 4 8 2 3 7 6 5 11 10 13 16 14 15 12 19 9 17 20 23 26 21 24 22 25 27 1 7 6 2 4 11 5 3 8 20 10 14 9 13 17 16 12 21 15 18 25 19 23 24 26 27 1 6 10 2 3 14 4 5 7 19 11 13 9 12 15 18 8 23 16 20 26 17 22 24 25 27 1 3 6 2 4 16 5 7 9 22 10 12 8 13 14 18 11 20 15 23 26 17 19 24 25 27 1 3 7 2 5 14 6 4 9 21 10 11 8 12 16 18 13 17 15 22 26 20 23 24 25 27 1 7 14 2 3 6 5 4 10 21 8 13 11 9 20 19 12 22 15 23 26 16 17 24 25 27 2 1 5 7 4 3 10 18 6 9 11 8 16 15 17 12 14 13 24 20 23 21 27 26 22 25 1 3 12 2 4 16 5 6 11 14 15 8 7 9 13 18 10 17 21 22 25 20 26 23 24 27 1 3 7 2 4 13 5 6 10 12 16 11 14 9 18 15 8 17 22 21 25 20 26 23 24 27 1 3 14 2 4 16 5 8 11 10 15 12 9 7 18 13 6 17 23 20 25 19 24 22 26 27 2 1 6 3 7 17 8 4 9 5 10 12 16 14 11 20 13 22 18 23 27 19 24 21 25 26 2 1 7 3 5 12 9 4 8 6 10 11 15 14 13 18 17 16 19 24 25 21 27 20 23 26 1 2 3 5 6 15 8 4 9 7 10 13 17 12 14 19 11 16 18 26 27 23 25 20 21 24 1 2 7 4 5 13 8 3 9 6 10 14 17 11 16 19 12 15 18 23 25 21 27 22 24 26 1 3 8 2 5 7 6 4 11 9 12 10 13 14 18 15 17 16 20 19 25 22 26 23 24 27 1 3 2 5 8 4 6 15 7 12 11 9 13 18 14 20 17 19 22 23 10 26 21 24 25 27 1 3 2 4 7 5 10 20 6 9 12 8 11 16 14 19 18 17 22 24 13 26 25 23 21 27 1 3 6 2 5 14 8 19 7 4 10 9 16 12 13 11 17 20 24 18 15 23 25 22 26 27 1 5 3 2 4 13 7 12 6 10 8 17 15 11 18 16 14 21 20 19 9 24 27 22 25 26 1 7 2 4 5 13 11 20 6 3 9 14 15 8 12 10 17 21 25 19 16 24 26 22 23 27 1 6 2 4 3 16 8 11 5 7 10 12 19 9 15 13 17 22 23 21 14 24 27 18 25 26 2 4 1 3 6 12 9 16 8 5 13 11 15 14 7 10 17 20 24 19 18 23 26 21 25 27 2 3 1 4 11 5 12 14 9 8 6 7 16 22 19 10 21 15 24 13 20 26 27 17 25 23 2 1 5 7 3 12 13 14 4 6 10 9 8 18 17 20 16 11 24 23 19 26 25 22 15 27 2 3 1 8 9 7 19 18 5 10 4 13 14 11 16 6 20 15 24 12 17 25 26 27 22 23 4 1 2 7 5 3 15 20 10 6 11 13 16 12 17 8 19 14 21 9 18 22 27 23 24 26 2 3 6 5 4 1 16 20 8 7 11 15 17 10 14 9 19 13 21 12 18 25 27 22 24 26 1 10 5 9 2 3 18 19 8 16 4 13 7 11 15 6 20 12 21 14 17 26 27 23 24 25 1 3 9 4 2 18 13 15 5 12 6 8 10 14 7 22 19 16 17 23 11 25 26 20 21 27 2 7 1 8 3 11 9 10 5 14 12 4 6 17 16 18 13 15 23 21 27 24 25 19 22 26 3 1 9 5 8 2 12 7 4 17 14 6 10 16 13 18 15 11 20 24 19 22 27 21 23 25 2 5 4 7 1 15 8 11 3 12 10 6 9 13 17 19 14 16 21 23 22 25 27 20 24 26 1 3 5 4 2 15 9 6 10 7 11 8 12 14 13 19 17 16 24 23 20 25 26 21 22 27 2 6 1 3 4 12 8 10 7 17 9 5 13 15 11 16 14 18 22 21 20 24 27 19 23 26 1 2 6 4 3 12 11 10 5 13 9 7 8 16 15 18 17 14 22 24 19 25 27 20 21 26 1 2 10 3 4 16 5 6 7 18 11 8 9 12 15 22 13 14 17 27 23 24 21 20 25 26 1 2 6 5 3 13 12 11 4 10 9 7 8 16 14 18 17 15 23 24 19 25 26 21 22 27 6 2 5 4 3 7 11 9 10 1 8 14 12 17 13 15 16 18 21 22 24 23 27 25 19 26 7 6 4 3 5 2 10 9 14 1 8 12 16 17 13 15 11 22 18 21 26 23 27 25 19 24 8 4 5 6 3 1 9 11 14 2 7 15 13 10 19 12 18 16 17 22 20 24 27 23 21 26 7 3 4 1 5 9 12 6 13 2 8 11 15 18 14 16 10 21 19 20 26 23 25 27 17 24 8 6 2 3 4 5 13 9 12 1 7 10 16 17 14 15 11 22 19 20 25 23 26 27 18 24 9 8 4 6 7 2 13 5 11 1 3 20 12 10 24 16 15 21 18 17 14 25 27 19 22 26 1 9 8 3 5 2 7 4 11 6 10 17 14 12 21 13 16 20 15 22 25 18 23 24 26 27 9 3 1 6 5 10 7 4 14 2 8 15 12 11 16 19 17 25 18 24 23 21 26 22 20 27 (Reprinted) JAMA Oncology July 2015 Volume 1, Number 4 Japan Nigeria a 3 9 5 4 6 1 2 7 16 11 17 13 8 12 14 18 20 10 21 19 23 25 22 15 26 24 27 Nigeria a 7 3 1 5 4 10 9 8 13 2 6 15 11 12 14 18 17 21 20 23 25 22 26 24 19 27</cell></row></table><note><p><s>Colors correspond to the ranking, with dark red as the most common cancer and dark green as the least common cancer for the location indicated.Rankings do not include the "other cancer" group (eTable 15 in the Supplement).The numbers inside each box indicate the ranking.a</s><s>Developing country.</s><s>b Democratic Republic of Congo.</s><s>Colors correspond to the ranking, with dark red as the cancer with the most deaths and dark green as the cancer with the least deaths for the location indicated.</s><s>Rankings do not include the "other cancer" group (eTable 15 in the Supplement).</s><s>The numbers inside each box indicate the ranking.</s><s>a Developing country.</s><s>b Democratic Republic of Congo.</s><s>The Global Burden of Cancer 2013 Special Communication Clinical Review &amp; Education jamaoncology.com</s><s>(Reprinted) JAMA Oncology July Volume 1, Number 4</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head></head><label></label><figDesc><div><p><s>The "other cancers" group (eTable 15 in the Supplement) is not included here because it contains multiple different types of cancers.</s><s>Solid lines connecting the 1990 and 2013 charts indicate increased or unchanged rank for the connected cancers; dotted lines indicated decreased rank.</s></p></div></figDesc><table><row><cell></cell><cell>1990</cell><cell>2013</cell><cell></cell><cell>Change in</cell><cell>Change in YLL Age-Standardized</cell></row><row><cell>Rank</cell><cell>Cancer</cell><cell>Cancer</cell><cell>Rank</cell><cell>Absolute YLLs, %</cell><cell>Rate, %</cell></row><row><cell>1</cell><cell>Tracheal, bronchus, and lung cancer</cell><cell>Tracheal, bronchus, and lung cancer</cell><cell>1</cell><cell>39.2</cell><cell>-17.6</cell></row><row><cell>2</cell><cell>Stomach cancer</cell><cell>Liver cancer</cell><cell>2</cell><cell>42.2</cell><cell>-13.7</cell></row><row><cell>3</cell><cell>Liver cancer</cell><cell>Stomach cancer</cell><cell>3</cell><cell>-2.5</cell><cell>-41.9</cell></row><row><cell>4</cell><cell>Colon and rectum cancer</cell><cell>Colon and rectum cancer</cell><cell>4</cell><cell>43.9</cell><cell>-15.6</cell></row><row><cell>5</cell><cell>Leukemia</cell><cell>Breast cancer</cell><cell>5</cell><cell>36.9</cell><cell>-19.6</cell></row><row><cell>6</cell><cell>Breast cancer</cell><cell>Esophageal cancer</cell><cell>6</cell><cell>31.9</cell><cell>-22.8</cell></row><row><cell>7</cell><cell>Esophageal cancer</cell><cell>Leukemia</cell><cell>7</cell><cell>-9.0</cell><cell>-31.0</cell></row><row><cell>8</cell><cell>Cervical cancer</cell><cell>Pancreatic cancer</cell><cell>8</cell><cell>73.7</cell><cell>1.4</cell></row><row><cell>9</cell><cell>Brain and nervous system cancer</cell><cell>Cervical cancer</cell><cell>9</cell><cell>13.7</cell><cell>-32.4</cell></row><row><cell>10</cell><cell>Non-Hodgkin lymphoma</cell><cell>Brain and nervous system cancer</cell><cell>10</cell><cell>26.4</cell><cell>-13.4</cell></row><row><cell>11</cell><cell>Pancreatic cancer</cell><cell>Non-Hodgkin lymphoma</cell><cell>11</cell><cell>42.3</cell><cell>-3.7</cell></row><row><cell>12</cell><cell>Ovarian cancer</cell><cell>Ovarian cancer</cell><cell>12</cell><cell>50.0</cell><cell>-11.4</cell></row><row><cell>13</cell><cell>Bladder cancer</cell><cell>Prostate cancer</cell><cell>13</cell><cell>69.7</cell><cell>-4.0</cell></row><row><cell>14</cell><cell>Gallbladder and biliary tract cancer</cell><cell>Lip and oral cavity cancer</cell><cell>14</cell><cell>52.4</cell><cell>-9.9</cell></row><row><cell>15</cell><cell>Prostate cancer</cell><cell>Kidney cancer</cell><cell>15</cell><cell>43.9</cell><cell>-8.8</cell></row><row><cell>16</cell><cell>Lip and oral cavity cancer</cell><cell>Bladder cancer</cell><cell>16</cell><cell>17.9</cell><cell>-31.4</cell></row><row><cell>17</cell><cell>Kidney cancer</cell><cell>Gallbladder and biliary tract cancer</cell><cell>17</cell><cell>11.3</cell><cell>-35.4</cell></row><row><cell>18</cell><cell>Larynx cancer</cell><cell>Other pharynx cancer</cell><cell>18</cell><cell>54.7</cell><cell>-9.3</cell></row><row><cell>19</cell><cell>Nasopharynx cancer</cell><cell>Larynx cancer</cell><cell>19</cell><cell>5.8</cell><cell>-37.5</cell></row><row><cell>20</cell><cell>Hodgkin lymphoma</cell><cell>Nasopharynx cancer</cell><cell>20</cell><cell>3.9</cell><cell>-35.5</cell></row><row><cell>21</cell><cell>Other pharynx cancer</cell><cell>Multiple myeloma</cell><cell>21</cell><cell>64.3</cell><cell>-3.8</cell></row><row><cell>22</cell><cell>Uterine cancer</cell><cell>Uterine cancer</cell><cell>22</cell><cell>35.6</cell><cell>-20.0</cell></row><row><cell>23</cell><cell>Malignant skin melanoma</cell><cell>Malignant skin melanoma</cell><cell>23</cell><cell>32.6</cell><cell>-19.3</cell></row><row><cell>24</cell><cell>Multiple myeloma</cell><cell>Hodgkin lymphoma</cell><cell>24</cell><cell>-40.5</cell><cell>-55.5</cell></row><row><cell>25</cell><cell>Thyroid cancer</cell><cell>Mesothelioma</cell><cell>25</cell><cell>82.9</cell><cell>9.9</cell></row><row><cell>26</cell><cell>Mesothelioma</cell><cell>Thyroid cancer</cell><cell>26</cell><cell>29.8</cell><cell>-21.8</cell></row><row><cell>27</cell><cell>Testicular cancer</cell><cell>Testicular cancer</cell><cell>27</cell><cell>11.4</cell><cell>-23.4</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head></head><label></label><figDesc><div><p><s>to 40.40) and by 8% in developed countries (69.75 to 74.98) (web table 1).</s><s>Age-standardized DALY rates have decreased by 17% at the global</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Decomposition Analysis of Cancer Trends in Global Incidence, Both Sexes, 1990 to 2013 Cancer groups are defined based on ICD codes and include all codes pertaining to neoplasms (ICD-9 140-239; ICD-10 C00-D49) except for NMSC and KS.</s><s>eTable 3 in the Supplement details how the original ICD codes were mapped to the standardized GBD cause list. 1 b To estimate the effect of population growth we applied the population size of 2013 onto the rate, sex, and age structure of 1990.</s><s>Since the global population grew by 35% between 1990 and 2013, and rates and age structure remained the same as in 1990, incidence due to all cancers increased by 35% in this counterfactual scenario.</s><s>c To estimate the effect of aging on incident cases we applied the age structure of 2013 onto the rate, sex distribution, and population size of 1990.</s><s>The change in incident cases reported herein shows the proportion of the change in incident cases between 1990 and 2013 that can be attributed to the changing age structure of the population.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Incident Cases, No.</cell><cell cols="2">Expected Incident Cases, 2013, No.</cell><cell cols="3">Change in Incident Cases, 1990 to 2013, %</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Due to</cell><cell>Due to Change</cell><cell>Due to Change</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Given Population</cell><cell>Given Population</cell><cell>Population</cell><cell>in Age</cell><cell>in Incidence</cell></row><row><cell>Cancer a</cell><cell>1990</cell><cell>2013</cell><cell>Growth Alone</cell><cell>Growth and Aging</cell><cell>Growth b</cell><cell>Structure c</cell><cell>Rates d</cell></row><row><cell>All except NMSC and KS</cell><cell>8 510 588</cell><cell>14 942 583</cell><cell>11 486 507</cell><cell>14 515 059</cell><cell>35.0</cell><cell>35.6</cell><cell>5.0</cell></row><row><cell>Esophageal</cell><cell>303 510</cell><cell>441 767</cell><cell>409 640</cell><cell>530 592</cell><cell>35.0</cell><cell>39.9</cell><cell>−29.3</cell></row><row><cell>Stomach</cell><cell>800 136</cell><cell>984 206</cell><cell>1 079 922</cell><cell>1 401 995</cell><cell>35.0</cell><cell>40.3</cell><cell>−52.2</cell></row><row><cell>Liver</cell><cell>465 014</cell><cell>792 203</cell><cell>627 617</cell><cell>800 507</cell><cell>35.0</cell><cell>37.2</cell><cell>−1.8</cell></row><row><cell>Larynx</cell><cell>137 785</cell><cell>176 687</cell><cell>185 964</cell><cell>238 499</cell><cell>35.0</cell><cell>38.1</cell><cell>−44.9</cell></row><row><cell>Tracheal, bronchus</cell><cell>1 113 162</cell><cell>1 798 179</cell><cell>1 502 405</cell><cell>1 937 791</cell><cell>35.0</cell><cell>39.1</cell><cell>−12.5</cell></row><row><cell>and lung</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Breast</cell><cell>906 618</cell><cell>1 804 209</cell><cell>1 223 637</cell><cell>1 568 145</cell><cell>35.0</cell><cell>38.0</cell><cell>26.0</cell></row><row><cell>Cervical</cell><cell>447 344</cell><cell>485 297</cell><cell>603 768</cell><cell>747 821</cell><cell>35.0</cell><cell>32.2</cell><cell>−58.7</cell></row><row><cell>Uterine</cell><cell>216 793</cell><cell>353 117</cell><cell>292 599</cell><cell>375 986</cell><cell>35.0</cell><cell>38.5</cell><cell>−10.5</cell></row><row><cell>Prostate</cell><cell>454 412</cell><cell>1 442 460</cell><cell>613 308</cell><cell>801 983</cell><cell>35.0</cell><cell>41.5</cell><cell>140.9</cell></row><row><cell>Colon and rectum</cell><cell>818 440</cell><cell>1 572 590</cell><cell>1 104 626</cell><cell>1 443 985</cell><cell>35.0</cell><cell>41.5</cell><cell>15.7</cell></row><row><cell>Lip and oral cavity</cell><cell>238 789</cell><cell>409 360</cell><cell>322 287</cell><cell>413 567</cell><cell>35.0</cell><cell>38.2</cell><cell>−1.8</cell></row><row><cell>Nasopharynx</cell><cell>67 658</cell><cell>83 702</cell><cell>91 316</cell><cell>112 072</cell><cell>35.0</cell><cell>30.7</cell><cell>−41.9</cell></row><row><cell>Other pharynx</cell><cell>80 691</cell><cell>139 567</cell><cell>108 907</cell><cell>140 604</cell><cell>35.0</cell><cell>39.3</cell><cell>−1.3</cell></row><row><cell>Gallbladder and</cell><cell>136 503</cell><cell>186 253</cell><cell>184 234</cell><cell>242 255</cell><cell>35.0</cell><cell>42.5</cell><cell>−41.0</cell></row><row><cell>biliary tract</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Pancreatic</cell><cell>183 076</cell><cell>350 361</cell><cell>247 093</cell><cell>323 423</cell><cell>35.0</cell><cell>41.7</cell><cell>14.7</cell></row><row><cell>Malignant skin melanoma</cell><cell>151 601</cell><cell>272 481</cell><cell>204 612</cell><cell>254 748</cell><cell>35.0</cell><cell>33.1</cell><cell>11.7</cell></row><row><cell>Ovarian</cell><cell>137 417</cell><cell>226 204</cell><cell>185 467</cell><cell>234 642</cell><cell>35.0</cell><cell>35.8</cell><cell>−6.1</cell></row><row><cell>Testicular</cell><cell>37 982</cell><cell>59 279</cell><cell>51 263</cell><cell>56 101</cell><cell>35.0</cell><cell>12.7</cell><cell>8.4</cell></row><row><cell>Kidney</cell><cell>142 463</cell><cell>294 501</cell><cell>192 279</cell><cell>241 697</cell><cell>35.0</cell><cell>34.7</cell><cell>37.1</cell></row><row><cell>Bladder</cell><cell>263 307</cell><cell>401 174</cell><cell>355 378</cell><cell>466 220</cell><cell>35.0</cell><cell>42.1</cell><cell>−24.7</cell></row><row><cell>Brain and central</cell><cell>193 980</cell><cell>304 528</cell><cell>261 809</cell><cell>293 291</cell><cell>35.0</cell><cell>16.2</cell><cell>5.8</cell></row><row><cell>nervous system</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Thyroid</cell><cell>115 627</cell><cell>225 566</cell><cell>156 058</cell><cell>187 946</cell><cell>35.0</cell><cell>27.6</cell><cell>32.5</cell></row><row><cell>Mesothelioma</cell><cell>16 972</cell><cell>33 744</cell><cell>22 906</cell><cell>29 561</cell><cell>35.0</cell><cell>39.2</cell><cell>24.6</cell></row><row><cell>Hodgkin lymphoma</cell><cell>103 249</cell><cell>93 345</cell><cell>139 353</cell><cell>142 599</cell><cell>35.0</cell><cell>3.1</cell><cell>−47.7</cell></row><row><cell>Non-Hodgkin lymphoma</cell><cell>226 661</cell><cell>465 488</cell><cell>305 918</cell><cell>373 548</cell><cell>35.0</cell><cell>29.8</cell><cell>40.6</cell></row><row><cell>Multiple myeloma</cell><cell>62 738</cell><cell>116 947</cell><cell>84 676</cell><cell>110 140</cell><cell>35.0</cell><cell>40.6</cell><cell>10.8</cell></row><row><cell>Leukemia</cell><cell>297 404</cell><cell>414 443</cell><cell>401 398</cell><cell>437 862</cell><cell>35.0</cell><cell>12.3</cell><cell>−7.9</cell></row><row><cell>Other neoplasms</cell><cell>391 255</cell><cell>1 014 928</cell><cell>528 066</cell><cell>607 480</cell><cell>35.0</cell><cell>20.3</cell><cell>104.1</cell></row></table><note><p><s>Abbreviations: GBD, Global Burden of Disease; ICD-9, International Classification of Diseases, Ninth Revision; ICD-10, International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; KS, Kaposi sarcoma; NMSC, nonmelanoma skin cancer; YLDs, years lived with disability; YLLs, years of life lost.</s><s>a</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head></head><label></label><figDesc><div><p><s>Trends in Age-Standardized Incidence Rates for Female Breast Cancer, 1990-2013</s></p></div></figDesc><table><row><cell cols="4">Clinical Review &amp; Education Special Communication</cell><cell>The Global Burden of Cancer 2013</cell></row><row><cell cols="5">ally in 2013, with 57% occurring in developed countries, and 43%</cell></row><row><cell cols="5">occurring in developing countries (web table 9). The probability of</cell></row><row><cell cols="5">developing prostate cancer is detailed in eTable 17 in the Supple-Breast cancer ment, with 1 in 15 men developing prostate cancer between birth and</cell></row><row><cell cols="5">100 80 40 age 79 years. Our web tables 4 and 5 detail how incidence rates per 100 000 in Developed countries Developing countries 2013 were the lowest in south Asia (with ASDRs per 100 000 reported for comparison) (ASIR, 9.9; ASDR, 2.39), east Asia (ASIR, 13.99; ASDR, 3.43), and central Asia (ASIR, 25.57; ASDR, 7.91) and the highest in high-Age-Standardized Incidence per 100 000 60 income North America (ASIR, 184.23; ASDR, 19.7), the Caribbean (ASIR, Global 154.97; ASDR, 49.05), and Australasia (ASIR, 144.81; ASDR, 26.53).</cell></row><row><cell>20</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1990</cell><cell>1995</cell><cell>2000</cell><cell>2005</cell><cell>2010</cell></row><row><cell></cell><cell></cell><cell>Year</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_11"><head></head><label></label><figDesc><div><p><s>.81).eFigure 4a in the Supplement shows that gallbladder and biliary tract cancer is exceptionally common in Chile, Bolivia, and South Korea, where it ranks sixth and seventh for cancer incident cases vs most other countries, where it is much less common.Specific ASIRs per 100 000 confirm this finding:14.85 in  Bolivia, 11.54 in South Korea, and 16.03in Chile (web table7).</s></p></div></figDesc><table><row><cell>Global Burden of Cancer 2013</cell><cell>Special Communication Clinical Review &amp; Education</cell></row><row><cell cols="2">jamaoncology.com with a smaller relative decrease of 18% in developing countries (from 3.09 to 2.52) compared with a 25% decrease in developed coun-tries (from 5.1 to 3Larynx cancer ASIRs per 100 000 for both sexes decreased glob-ally by 25% (from 3.7 to 2.78), with a smaller decrease of 14% in developing countries (from 3.22 to 2.76) compared with a 37% de-(Reprinted) JAMA Oncology July 2015 Volume 1, Number 4 der and biliary tract cancer decreased by 23% (from 3.99 to 3.09), crease in developed countries (4.62 to 2.92).</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">JAMA Oncology July 2015 Volume 1, Number 4 (Reprinted) jamaoncology.com Copyright 2015 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 05/17/2022</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Copyright 2015 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 05/17/2022</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Copyright 2015 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 05/17/2022 Copyright 2015 American Medical Association. All rights reserved.</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Author Contributions: Drs Fitzmaurice and Naghavi had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</s><s>Study concept and design: Fitzmaurice, Dicker, Pain, MacIntyre, Hansen, Leigh, <ref type="bibr">Younis, Marcenes, Tillmann, Forouzanfar, Lopez, Murray, Naghavi. Acquisition, analysis, or</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<idno type="DOI">http://jama.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.0735&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamaoncol.2015.0735</idno>
		<title level="m">for Publication</title>
				<imprint>
			<date type="published" when="2015-04-09">April 9. 2015. May 28. 2015</date>
		</imprint>
	</monogr>
	<note>Published Online</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">The Global Burden of Disease Cancer Collaboration</title>
		<imprint>
			<pubPlace>Christina Fitzmaurice, MD, MPH</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Daniel</forename><surname>Dicker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Bs; Amanda Pain</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Hannah</forename><surname>Hamavid</surname></persName>
		</author>
		<author>
			<persName><surname>Ba; Maziar Moradi-Lakeh</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, MPH</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Michael</forename><forename type="middle">F</forename><surname>Macintyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Edm; Christine</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><surname>Ba; Gillian</surname></persName>
		</author>
		<author>
			<persName><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Woodbrook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mlis; Charles</forename><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Md; Randah</surname></persName>
		</author>
		<author>
			<persName><surname>Hamadeh</surname></persName>
		</author>
		<author>
			<persName><surname>Bsc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dphil; Ami</forename><surname>Msc</surname></persName>
		</author>
		<author>
			<persName><surname>Moore</surname></persName>
		</author>
		<imprint>
			<publisher>PhD</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Werdecker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dipl.Oec</title>
		<imprint/>
	</monogr>
	<note>Troph</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Bradford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Gessner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><forename type="middle">;</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Mph; Brian</forename><surname>Braden Te Ao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Chante</forename><surname>Mcmahon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ba; Chuanhua</forename><surname>Karimkhani</surname></persName>
		</author>
		<author>
			<persName><surname>Yu</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Graham</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Dphil</forename><surname>Cooke</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd</forename><surname>Schwebel</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">David</forename><forename type="middle">O</forename><surname>Carpenter</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">David</forename><forename type="middle">M</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Denis</forename><surname>Nash</surname></persName>
		</author>
		<author>
			<persName><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mph; Dhruv</surname></persName>
		</author>
		<author>
			<persName><surname>Kazi</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ms; Diego De</forename><surname>Msc</surname></persName>
		</author>
		<author>
			<persName><surname>Leo</surname></persName>
		</author>
		<imprint>
			<pubPlace>DSc, PhD, MD; Dietrich Plass, Dr</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">N</forename><surname>Kingsley</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Mbbs</forename><surname>Ukwaja</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">George</forename><forename type="middle">D</forename><surname>Thurston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Scd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename><surname>Kim Yun</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Edgar</surname></persName>
		</author>
		<author>
			<persName><surname>Simard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Edward</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Eun-Kee</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><surname>Park</surname></persName>
		</author>
		<author>
			<persName><surname>Phd; Ferrán Catalá-López</surname></persName>
		</author>
		<author>
			<persName><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><surname>Mph; Gabrielle Deveber</surname></persName>
		</author>
		<author>
			<persName><surname>Md; Carolyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Gulfaraz</forename><surname>Gotay</surname></persName>
		</author>
		<author>
			<persName><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><forename type="middle">H</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iii</forename><surname>Dean Hosgood</surname></persName>
		</author>
		<imprint>
			<publisher>PhD</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Itamar</surname></persName>
		</author>
		<author>
			<persName><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Janet</surname></persName>
		</author>
		<author>
			<persName><surname>Leasher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Od</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Faao; Jasvinder</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; James</forename><surname>Leigh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Msc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Juan</forename><surname>Jonas</surname></persName>
		</author>
		<author>
			<persName><surname>Sanabria</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Frcsc</forename><surname>Msc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Facs; Justin</forename><surname>Beardsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fracp; Kathryn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Ken</forename><surname>Jacobsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Richard</surname></persName>
		</author>
		<author>
			<persName><surname>Franklin</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD, MSocSc, BSc</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Luca</forename><surname>Ronfani</surname></persName>
		</author>
		<author>
			<persName><surname>Phd; Marcella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Msc; Luigi</forename><surname>Montico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Marcello</forename><surname>Naldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Johanna</forename><surname>Tonelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Max</forename><surname>Geleijnse</surname></persName>
		</author>
		<author>
			<persName><surname>Petzold</surname></persName>
		</author>
		<imprint>
			<pubPlace>Mark G Shrime, MD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Mustafa</forename><surname>Younis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><surname>Mba; Naohiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Nicholas</forename><surname>Yonemoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Paul</forename><surname>Breitborde</surname></persName>
		</author>
		<author>
			<persName><surname>Yip</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Farshad</forename><surname>Pourmalek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paulo</surname></persName>
		</author>
		<author>
			<persName><surname>Lotufo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Drph; Alireza</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><surname>Esteghamati</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Graeme</forename><forename type="middle">J</forename><surname>Hankey</surname></persName>
		</author>
		<author>
			<persName><surname>Mbbs</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><surname>Fracp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Frcpe</forename><surname>Frcp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Faha; Raghib</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Frcp; Raimundas</forename><surname>Lunevicius</surname></persName>
		</author>
		<author>
			<persName><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dr; Reza</forename><surname>Habil</surname></persName>
		</author>
		<author>
			<persName><surname>Malekzadeh</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Robert</forename><surname>Dellavalle</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Msph; Robert</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Weintraub</surname></persName>
		</author>
		<author>
			<persName><surname>Bs</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Robyn</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><surname>Bsc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Mbchb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Mhe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fafphm; Roderick</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><surname>Hay</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">David</forename><surname>Rojas-Rueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Ronny</forename><surname>Westerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sadaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Sepanlou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><forename type="middle">;</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Sandra</forename><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Scott</forename><surname>Patten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Scott</forename><surname>Weichenthal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PhD; Semaw Ferede Abera</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title/>
		<author>
			<persName><surname>Seyed-Mohammad Fereshtehnejad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Msc; Ivy</forename><surname>Shiue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Tim</forename><surname>Driscoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mbbs</forename><surname>Bsc(med</surname></persName>
		</author>
		<author>
			<persName><forename type="first">)</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Mohs</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Tommi</forename><surname>Vasankari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Ubai</forename><surname>Alsharif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dmd</forename><surname>Mph; Vafa Rahimi-Movaghar</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Vasiliy</surname></persName>
		</author>
		<author>
			<persName><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><forename type="middle">S</forename><surname>Md; W</surname></persName>
		</author>
		<author>
			<persName><surname>Marcenes</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>PhD</note>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Wubegzier</forename><surname>Mekonnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Yuichiro</forename><surname>Phd; Yohannes Adama Melaku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Yano</surname></persName>
		</author>
		<author>
			<persName><surname>Artaman</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Campos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Jennifer</forename><surname>Maclachlan</surname></persName>
		</author>
		<imprint>
			<pubPlace>MSc (Epi</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Ulrich</forename><surname>Mueller</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Daniel</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Drph; Matias</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><surname>Trillini</surname></persName>
		</author>
		<author>
			<persName><surname>Md; Babak</surname></persName>
		</author>
		<author>
			<persName><surname>Eshrati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hywel</surname></persName>
		</author>
		<author>
			<persName><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><surname>Dsc; Kenji</surname></persName>
		</author>
		<author>
			<persName><surname>Shibuya</surname></persName>
		</author>
		<author>
			<persName><surname>Md; Rakhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Kinnari</forename><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mbbs</forename><surname>Murthy</surname></persName>
		</author>
		<author>
			<persName><surname>Mph; Benjamin Cowie</surname></persName>
		</author>
		<author>
			<persName><surname>Mbbs</surname></persName>
		</author>
		<author>
			<persName><surname>Phd</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<author>
			<persName><forename type="first">T</forename><surname>Azmeraw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph</forename><surname>Amare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Msc; Carl Abelardo</forename><surname>Antonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Carlos</forename><surname>Castañeda-Orjuela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Msc; Coen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Gool</surname></persName>
		</author>
		<title level="m">PhD; Francesco Violante, MD; In-Hwan</title>
				<meeting><address><addrLine>Oh, MD, PhD</addrLine></address></meeting>
		<imprint>
			<publisher>MPH</publisher>
		</imprint>
	</monogr>
	<note>Kedede Deribe</note>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Kjetil</forename><surname>Soreide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Luke</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Maia</forename><surname>Knibbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Kereselidze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Mark</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Rosario</forename><surname>Cardenas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Scd; Nobhojit</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Mph; Taavi Tillmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mbchb; Yongmei</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Hans</forename><surname>Krueger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Lorenzo</forename><surname>Monasta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dsc; Subhojit</forename><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; Sara</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Sheikhbahaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Mph; Nima Hafezi-Nejad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mph; G. Anil</forename><surname>Kumar</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title level="m">Department of Neurobiology Care Sciences and Society (NVS), Karolinska Institutet</title>
				<meeting><address><addrLine>Stockholm, Sweden (Fereshtehnejad</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title level="m" type="main">Barts and The London School of Medicine and Dentistry</title>
		<imprint>
			<publisher>School of Public Health</publisher>
			<pubPlace>Moscow, Russia (Vlassov; London, England (Marcenes; Addis Ababa University, Addis Ababa, Ethiopia (Mekonnen, Deribe; Chicago, Illinois (Yano</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran (Rahimi-Movaghar); National Research University Higher School of Economics ; University of London ; Mekelle University, Mekelle, Ethiopia (Melaku); Department of Preventive Medicine, Northwestern University</orgName>
		</respStmt>
	</monogr>
	<note>College of Health Sciences</note>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Ontario</forename><surname>Windsor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Canada</forename></persName>
		</author>
		<imprint>
			<publisher>Artaman</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The Peter Doherty Institute for Infection and Immunity, WHO Collaborating Centre for Viral Hepatitis</title>
	</analytic>
	<monogr>
		<title level="m">Victorian Infectious Diseases Reference Laboratory (VIDRL)</title>
				<meeting><address><addrLine>Melbourne, Australia (MacLachlan, Cowie</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<title level="m" type="main">Public Health Foundation of India, National Capital Region</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><surname>Murthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><surname>Dandona</surname></persName>
		</author>
		<imprint>
			<pubPlace>India</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title level="m" type="main">Colombia (Castañeda-Orjuela); National Institute for Public Health and the Environment</title>
		<imprint>
			<pubPlace>Bogota; Bilthoven, the Netherlands (van Gool; Bologna, Italy (Violante</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Colombian National Health Observatory Instituto Nacional de Salud ; Department of Medical and Surgical Sciences, University of Bologna</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main">National Centre for Diseases Control and Public Health</title>
		<imprint>
			<pubPlace>Brisbane, Australia (Knibbs); Tbilisi, Georgia (Kereselidze; Sheffield, England (Green</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Department of Clinical Medicine, The University of Queensland ; University of Sheffield</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Department of Public Health Sciences</title>
	</analytic>
	<monogr>
		<title level="j">Karolinska Institutet</title>
		<imprint/>
		<respStmt>
			<orgName>Universidad Autonoma Metropolitana</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title level="m" type="main">Faculty of Medicine and Health Sciences</title>
		<imprint>
			<pubPlace>India (Dey; Malaysia</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Indian Institute of Public Health, National Capital Region ; Universiti Tunku Abdul Rahman Selangor</orgName>
		</respStmt>
	</monogr>
	<note>Sreeramareddy</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Critical revision of the manuscript for important intellectual content</title>
		<author>
			<persName><forename type="first">Cooke</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><surname>Schwebel</surname></persName>
		</author>
		<author>
			<persName><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><surname>Nash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Kazi</surname></persName>
		</author>
		<author>
			<persName><surname>Leo</surname></persName>
		</author>
		<author>
			<persName><surname>Plass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Thurston</forename><surname>Ukwaja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yun</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><surname>Simard</surname></persName>
		</author>
		<author>
			<persName><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><surname>Park</surname></persName>
		</author>
		<author>
			<persName><surname>Catalá-López</surname></persName>
		</author>
		<author>
			<persName><surname>Gotay</surname></persName>
		</author>
		<author>
			<persName><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><surname>Hosgood</surname></persName>
		</author>
		<author>
			<persName><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><surname>Leasher</surname></persName>
		</author>
		<author>
			<persName><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jonas</forename><surname>Leigh</surname></persName>
		</author>
		<author>
			<persName><surname>Sanabria</surname></persName>
		</author>
		<author>
			<persName><surname>Beardsley</surname></persName>
		</author>
		<author>
			<persName><surname>Jacobsen</surname></persName>
		</author>
		<author>
			<persName><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><surname>Ronfani</surname></persName>
		</author>
		<author>
			<persName><surname>Montico</surname></persName>
		</author>
		<author>
			<persName><surname>Naldi</surname></persName>
		</author>
		<author>
			<persName><surname>Tonelli</surname></persName>
		</author>
		<author>
			<persName><surname>Geleijnse</surname></persName>
		</author>
		<author>
			<persName><surname>Petzold</surname></persName>
		</author>
		<author>
			<persName><surname>Shrime</surname></persName>
		</author>
		<author>
			<persName><surname>Younis</surname></persName>
		</author>
		<author>
			<persName><surname>Yonemoto</surname></persName>
		</author>
		<author>
			<persName><surname>Breitborde</surname></persName>
		</author>
		<author>
			<persName><surname>Yip</surname></persName>
		</author>
		<author>
			<persName><surname>Pourmalek</surname></persName>
		</author>
		<author>
			<persName><surname>Lotufo</surname></persName>
		</author>
		<author>
			<persName><surname>Esteghamati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ali</forename><surname>Hankey</surname></persName>
		</author>
		<author>
			<persName><surname>Lunevicius</surname></persName>
		</author>
		<author>
			<persName><surname>Malekzadeh</surname></persName>
		</author>
		<author>
			<persName><surname>Dellavalle</surname></persName>
		</author>
		<author>
			<persName><surname>Weintraub</surname></persName>
		</author>
		<author>
			<persName><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><surname>Rojas-Rueda</surname></persName>
		</author>
		<author>
			<persName><surname>Westerman</surname></persName>
		</author>
		<author>
			<persName><surname>Sepanlou</surname></persName>
		</author>
		<author>
			<persName><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><surname>Patten</surname></persName>
		</author>
		<author>
			<persName><surname>Abera</surname></persName>
		</author>
		<author>
			<persName><surname>Fereshtehnejad</surname></persName>
		</author>
		<author>
			<persName><surname>Shiue</surname></persName>
		</author>
		<author>
			<persName><surname>Driscoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alsharif</forename><surname>Vasankari</surname></persName>
		</author>
		<author>
			<persName><surname>Rahimi-Movaghar</surname></persName>
		</author>
		<author>
			<persName><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><surname>Marcenes</surname></persName>
		</author>
		<author>
			<persName><surname>Mekonnen</surname></persName>
		</author>
		<author>
			<persName><surname>Melaku</surname></persName>
		</author>
		<author>
			<persName><surname>Yano</surname></persName>
		</author>
		<author>
			<persName><surname>Artaman</surname></persName>
		</author>
		<author>
			<persName><surname>Campos</surname></persName>
		</author>
		<author>
			<persName><surname>Maclachlan</surname></persName>
		</author>
		<author>
			<persName><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><surname>Trillini</surname></persName>
		</author>
		<author>
			<persName><surname>Eshrati</surname></persName>
		</author>
		<author>
			<persName><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><surname>Shibuya</surname></persName>
		</author>
		<author>
			<persName><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><surname>Murthy</surname></persName>
		</author>
		<author>
			<persName><surname>Cowie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Antonio</forename><surname>Amare</surname></persName>
		</author>
		<author>
			<persName><surname>Castañeda-Orjuela</surname></persName>
		</author>
		<author>
			<persName><surname>Van Gool</surname></persName>
		</author>
		<author>
			<persName><surname>Violante</surname></persName>
		</author>
		<author>
			<persName><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><surname>Deribe</surname></persName>
		</author>
		<author>
			<persName><surname>Soreide</surname></persName>
		</author>
		<author>
			<persName><surname>Knibbs</surname></persName>
		</author>
		<author>
			<persName><surname>Kereselidze</surname></persName>
		</author>
		<author>
			<persName><surname>Green</surname></persName>
		</author>
		<author>
			<persName><surname>Cardenas</surname></persName>
		</author>
		<author>
			<persName><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><surname>Li</surname></persName>
		</author>
		<author>
			<persName><surname>Krueger</surname></persName>
		</author>
		<author>
			<persName><surname>Monasta</surname></persName>
		</author>
		<author>
			<persName><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><surname>Sheikhbahaei</surname></persName>
		</author>
		<author>
			<persName><surname>Hafezi-Nejad</surname></persName>
		</author>
		<author>
			<persName><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><surname>Sreeramareddy</surname></persName>
		</author>
		<author>
			<persName><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><surname>Vollset</surname></persName>
		</author>
		<author>
			<persName><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName><surname>Lozano</surname></persName>
		</author>
		<author>
			<persName><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Allen</forename><surname>Hamavid</surname></persName>
		</author>
		<author>
			<persName><surname>Woodbrook</surname></persName>
		</author>
		<author>
			<persName><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><surname>Sanabria</surname></persName>
		</author>
		<author>
			<persName><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><surname>Rojas-Rueda</surname></persName>
		</author>
		<author>
			<persName><surname>Vasankari</surname></persName>
		</author>
		<author>
			<persName><surname>Alsharif</surname></persName>
		</author>
		<author>
			<persName><surname>Sheikhbahaei</surname></persName>
		</author>
		<author>
			<persName><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><surname>Fitzmaurice</surname></persName>
		</author>
		<author>
			<persName><surname>Dicker</surname></persName>
		</author>
		<author>
			<persName><surname>Pain</surname></persName>
		</author>
		<author>
			<persName><surname>Hamavid</surname></persName>
		</author>
		<author>
			<persName><surname>Moradi-Lakeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Allen</forename><surname>Macintyre</surname></persName>
		</author>
		<author>
			<persName><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><surname>Hamadeh</surname></persName>
		</author>
		<author>
			<persName><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><surname>Werdecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Te</forename><surname>Gessner</surname></persName>
		</author>
		<author>
			<persName><surname>Ao</surname></persName>
		</author>
		<author>
			<persName><surname>Mcmahon</surname></persName>
		</author>
		<author>
			<persName><surname>Karimkhani</surname></persName>
		</author>
		<author>
			<persName><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><surname>Cooke</surname></persName>
		</author>
		<author>
			<persName><surname>Schwebel</surname></persName>
		</author>
		<author>
			<persName><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><surname>Nash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Kazi</surname></persName>
		</author>
		<author>
			<persName><surname>Leo</surname></persName>
		</author>
		<author>
			<persName><surname>Plass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Thurston</forename><surname>Ukwaja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yun</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><surname>Simard</surname></persName>
		</author>
		<author>
			<persName><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><surname>Park</surname></persName>
		</author>
		<author>
			<persName><surname>Catalá-López</surname></persName>
		</author>
		<author>
			<persName><surname>Gotay</surname></persName>
		</author>
		<author>
			<persName><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><surname>Hosgood</surname></persName>
		</author>
		<author>
			<persName><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><surname>Leasher</surname></persName>
		</author>
		<author>
			<persName><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jonas</forename><surname>Leigh</surname></persName>
		</author>
		<author>
			<persName><surname>Beardsley</surname></persName>
		</author>
		<author>
			<persName><surname>Jacobsen</surname></persName>
		</author>
		<author>
			<persName><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><surname>Ronfani</surname></persName>
		</author>
		<author>
			<persName><surname>Montico</surname></persName>
		</author>
		<author>
			<persName><surname>Naldi</surname></persName>
		</author>
		<author>
			<persName><surname>Tonelli</surname></persName>
		</author>
		<author>
			<persName><surname>Geleijnse</surname></persName>
		</author>
		<author>
			<persName><surname>Petzold</surname></persName>
		</author>
		<author>
			<persName><surname>Shrime</surname></persName>
		</author>
		<author>
			<persName><surname>Younis</surname></persName>
		</author>
		<author>
			<persName><surname>Yonemoto</surname></persName>
		</author>
		<author>
			<persName><surname>Breitborde</surname></persName>
		</author>
		<author>
			<persName><surname>Yip</surname></persName>
		</author>
		<author>
			<persName><surname>Pourmalek</surname></persName>
		</author>
		<author>
			<persName><surname>Lotufo</surname></persName>
		</author>
		<author>
			<persName><surname>Esteghamati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ali</forename><surname>Hankey</surname></persName>
		</author>
		<author>
			<persName><surname>Lunevicius</surname></persName>
		</author>
		<author>
			<persName><surname>Malekzadeh</surname></persName>
		</author>
		<author>
			<persName><surname>Dellavalle</surname></persName>
		</author>
		<author>
			<persName><surname>Weintraub</surname></persName>
		</author>
		<author>
			<persName><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><surname>Rojas-Rueda</surname></persName>
		</author>
		<author>
			<persName><surname>Westerman</surname></persName>
		</author>
		<author>
			<persName><surname>Sepanlou</surname></persName>
		</author>
		<author>
			<persName><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><surname>Patten</surname></persName>
		</author>
		<author>
			<persName><surname>Abera</surname></persName>
		</author>
		<author>
			<persName><surname>Fereshtehnejad</surname></persName>
		</author>
		<author>
			<persName><surname>Shiue</surname></persName>
		</author>
		<author>
			<persName><surname>Driscoll</surname></persName>
		</author>
		<author>
			<persName><surname>Rahimi-Movaghar</surname></persName>
		</author>
		<author>
			<persName><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><surname>Marcenes</surname></persName>
		</author>
		<author>
			<persName><surname>Mekonnen</surname></persName>
		</author>
		<author>
			<persName><surname>Melaku</surname></persName>
		</author>
		<author>
			<persName><surname>Yano</surname></persName>
		</author>
		<author>
			<persName><surname>Artaman</surname></persName>
		</author>
		<author>
			<persName><surname>Campos</surname></persName>
		</author>
		<author>
			<persName><surname>Maclachlan</surname></persName>
		</author>
		<author>
			<persName><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><surname>Trillini</surname></persName>
		</author>
		<author>
			<persName><surname>Eshrati</surname></persName>
		</author>
		<author>
			<persName><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><surname>Shibuya</surname></persName>
		</author>
		<author>
			<persName><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><surname>Murthy</surname></persName>
		</author>
		<author>
			<persName><surname>Cowie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Antonio</forename><surname>Amare</surname></persName>
		</author>
		<author>
			<persName><surname>Castañeda-Orjuela</surname></persName>
		</author>
		<author>
			<persName><surname>Van Gool</surname></persName>
		</author>
		<author>
			<persName><surname>Violante</surname></persName>
		</author>
		<author>
			<persName><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><surname>Deribe</surname></persName>
		</author>
		<author>
			<persName><surname>Soreide</surname></persName>
		</author>
		<author>
			<persName><surname>Knibbs</surname></persName>
		</author>
		<author>
			<persName><surname>Kereselidze</surname></persName>
		</author>
		<author>
			<persName><surname>Green</surname></persName>
		</author>
		<author>
			<persName><surname>Cardenas</surname></persName>
		</author>
		<author>
			<persName><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><surname>Tillmann</surname></persName>
		</author>
		<author>
			<persName><surname>Li</surname></persName>
		</author>
		<author>
			<persName><surname>Krueger</surname></persName>
		</author>
		<author>
			<persName><surname>Monasta</surname></persName>
		</author>
		<author>
			<persName><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><surname>Hafezi-Nejad</surname></persName>
		</author>
		<author>
			<persName><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><surname>Sreeramareddy</surname></persName>
		</author>
		<author>
			<persName><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><surname>Vollset</surname></persName>
		</author>
		<author>
			<persName><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName><surname>Lozano</surname></persName>
		</author>
		<author>
			<persName><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><surname>Dicker</surname></persName>
		</author>
		<author>
			<persName><surname>Hamavid</surname></persName>
		</author>
		<author>
			<persName><surname>Moradi-Lakeh</surname></persName>
		</author>
		<author>
			<persName><surname>Woodbrook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yun</forename><surname>Ukwaja</surname></persName>
		</author>
		<author>
			<persName><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><surname>Simard</surname></persName>
		</author>
		<author>
			<persName><surname>Park</surname></persName>
		</author>
		<author>
			<persName><surname>Petzold</surname></persName>
		</author>
		<author>
			<persName><surname>Younis</surname></persName>
		</author>
		<author>
			<persName><surname>Yonemoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ali</forename><surname>Yip</surname></persName>
		</author>
		<author>
			<persName><surname>Rojas-Rueda</surname></persName>
		</author>
		<author>
			<persName><surname>Rahimi-Movaghar</surname></persName>
		</author>
		<author>
			<persName><surname>Marcenes</surname></persName>
		</author>
		<author>
			<persName><surname>Campos</surname></persName>
		</author>
		<author>
			<persName><surname>Maclachlan</surname></persName>
		</author>
		<author>
			<persName><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><surname>Cowie</surname></persName>
		</author>
		<author>
			<persName><surname>Kereselidze</surname></persName>
		</author>
		<author>
			<persName><surname>Cardenas</surname></persName>
		</author>
		<author>
			<persName><surname>Sreeramareddy</surname></persName>
		</author>
		<author>
			<persName><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Naghavi</forename><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Administrative</surname></persName>
		</author>
		<author>
			<persName><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><surname>Nash</surname></persName>
		</author>
		<author>
			<persName><surname>Simard</surname></persName>
		</author>
		<author>
			<persName><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><surname>Catalá-López</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iii</forename><surname>Hosgood</surname></persName>
		</author>
		<author>
			<persName><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jonas</forename><surname>Leigh</surname></persName>
		</author>
		<author>
			<persName><surname>Esteghamati</surname></persName>
		</author>
		<author>
			<persName><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><surname>Abera</surname></persName>
		</author>
		<author>
			<persName><surname>Vlassov</surname></persName>
		</author>
		<author>
			<persName><surname>Mekonnen</surname></persName>
		</author>
		<author>
			<persName><surname>Melaku</surname></persName>
		</author>
		<author>
			<persName><surname>Murthy</surname></persName>
		</author>
		<author>
			<persName><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><surname>Soreide</surname></persName>
		</author>
		<author>
			<persName><surname>Knibbs</surname></persName>
		</author>
		<author>
			<persName><surname>Green</surname></persName>
		</author>
		<author>
			<persName><surname>Monasta</surname></persName>
		</author>
		<author>
			<persName><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><surname>Dandona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Macintyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jonas</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><surname>Sanabria</surname></persName>
		</author>
		<author>
			<persName><surname>Malekzadeh</surname></persName>
		</author>
		<author>
			<persName><surname>Rojas-Rueda</surname></persName>
		</author>
		<author>
			<persName><surname>Westerman</surname></persName>
		</author>
		<author>
			<persName><surname>Marcenes</surname></persName>
		</author>
		<author>
			<persName><surname>Yano</surname></persName>
		</author>
		<author>
			<persName><surname>Mokdad</surname></persName>
		</author>
		<author>
			<persName><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Naghavi</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">technical, or material support: Dicker, Pain</title>
				<imprint>
			<date type="published" when="2013">2013. 2015</date>
			<biblScope unit="volume">385</biblScope>
			<biblScope unit="page" from="117" to="171" />
		</imprint>
	</monogr>
	<note>Study supervision: Pain. REFERENCES 1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Lozano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Naghavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Foreman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="issue">9867</biblScope>
			<biblScope unit="page" from="2095" to="2128" />
			<date type="published" when="2010">2010. 2013. 2012</date>
		</imprint>
	</monogr>
	<note>Lancet</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Mortality by cause for eight regions of the world: Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Lopez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="issue">9061</biblScope>
			<biblScope unit="page" from="1269" to="1276" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)</title>
		<author>
			<persName><forename type="first">C</forename><surname>Allemani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Weir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Carreira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">385</biblScope>
			<biblScope unit="issue">9972</biblScope>
			<biblScope unit="page" from="977" to="1010" />
			<date type="published" when="2015">2015</date>
		</imprint>
		<respStmt>
			<orgName>CONCORD Working Group</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Noone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Mariotto</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer</title>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1290" to="1314" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Coleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gatta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Verdecchia</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century</title>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="128" to="149" />
			<date type="published" when="2003">2003</date>
		</imprint>
		<respStmt>
			<orgName>EUROCARE Working Group</orgName>
		</respStmt>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">GBD 2010: design, definitions, and metrics</title>
		<author>
			<persName><forename type="first">Cjl</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ezzati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Flaxman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="issue">9859</biblScope>
			<biblScope unit="page" from="2063" to="2066" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Flaxman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="issue">9859</biblScope>
			<biblScope unit="page" from="2224" to="2260" />
			<date type="published" when="1990">1990-2010. 2010. 2012</date>
		</imprint>
	</monogr>
	<note>: a systematic analysis for the Global Burden of Disease Study</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">Cjl</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lozano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="issue">9867</biblScope>
			<biblScope unit="page" from="2197" to="2223" />
			<date type="published" when="2010">2010. 2013. 2012</date>
		</imprint>
	</monogr>
	<note>Lancet</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Freeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="issue">9859</biblScope>
			<biblScope unit="page" from="2144" to="2162" />
			<date type="published" when="2010">2010. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Hogan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="issue">9859</biblScope>
			<biblScope unit="page" from="2129" to="2143" />
			<date type="published" when="2010">2010. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">T</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Flaxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Naghavi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="issue">9867</biblScope>
			<biblScope unit="page" from="2163" to="2196" />
			<date type="published" when="2010">2010. 2013. 2012</date>
		</imprint>
	</monogr>
	<note>Lancet</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dwyer-Lindgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Lofgren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="issue">9859</biblScope>
			<biblScope unit="page" from="2071" to="2094" />
			<date type="published" when="2010">2010. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Liddell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Coates</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(14)60497-9</idno>
		<idno>doi:10 .1016/S0140-6736</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">384</biblScope>
			<biblScope unit="issue">9947</biblScope>
			<biblScope unit="page" from="60497" to="60499" />
			<date type="published" when="2013">2013. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<monogr>
		<author>
			<persName><forename type="first">R</forename><surname>Doll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Payne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Waterhouse</surname></persName>
		</author>
		<title level="m">Cancer Incidence in Five Continents</title>
				<meeting><address><addrLine>Geneva, Switzerland; Union Internationale Contre le Cancer</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1966">1966</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<monogr>
		<author>
			<persName><forename type="first">R</forename><surname>Doll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Muir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Waterhouse</surname></persName>
		</author>
		<title level="m">Cancer Incidence in Five Continents. Vol II</title>
				<meeting><address><addrLine>Geneva, Switzerland; Union Internationale Contre le Cancer</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1970">1970</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><surname>Waterhouse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Muir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Correa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Powell</surname></persName>
		</author>
		<title level="m">Cancer Incidence in Five Continents. Vol III</title>
				<meeting><address><addrLine>Lyon, France</addrLine></address></meeting>
		<imprint>
			<publisher>IARC</publisher>
			<date type="published" when="1976">1976</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><surname>Waterhouse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Muir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shanmugaratnam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Powell</surname></persName>
		</author>
		<title level="m">Cancer Incidence in Five Continents. Vol IV</title>
				<meeting><address><addrLine>Lyon, France: IARC</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<monogr>
		<author>
			<persName><forename type="first">C</forename><surname>Muir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Whelan</surname></persName>
		</author>
		<title level="m">Cancer Incidence in Five Continents</title>
				<meeting><address><addrLine>Lyon, France</addrLine></address></meeting>
		<imprint>
			<publisher>IARC</publisher>
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Prospective evaluation of analgesic use and risk of renal cell cancer</title>
		<author>
			<persName><forename type="first">E</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Curhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Hankinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="1487" to="1493" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Obesity, hypertension, and the risk of kidney cancer in men</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gridley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Fraumeni</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Järvholm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="1305" to="1311" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">L</forename><surname>Van Der Hel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Mcmillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boffetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Brennan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="101" to="108" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">International renal-cell cancer study, IV: occupation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Mandel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Mclaughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schlehofer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="601" to="605" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Korea&apos;s thyroid-cancer &quot;epidemic&quot;-screening and overdiagnosis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Welch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="1765" to="1767" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Nixon</surname></persName>
		</author>
		<idno type="DOI">10.1002/cncr.29289</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Increasing thyroid cancer incidence in Queensland, Australia 1982-2008: true increase or overdiagnosis?</title>
		<author>
			<persName><forename type="first">N</forename><surname>Pandeya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Mcleod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Balasubramaniam</surname></persName>
		</author>
		<idno type="DOI">10.1111/cen.12724</idno>
		<idno>doi:10 .1111/cen.12724</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Endocrinol</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<monogr>
		<title level="m" type="main">United Nations Millennium Development Goals</title>
		<ptr target="http://www.un.org/millenniumgoals/" />
		<imprint>
			<date type="published" when="2015-02-02">Accessed February 2, 2015</date>
		</imprint>
	</monogr>
	<note>United Nations</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ezzati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vander Hoorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cjl</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="issue">9343</biblScope>
			<biblScope unit="page" from="1347" to="1360" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Robinson</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(14)60460-8</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">384</biblScope>
			<biblScope unit="issue">9945</biblScope>
			<biblScope unit="page" from="766" to="781" />
			<date type="published" when="2013">2013. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
